syndrome	score	normalized_score
DRAVET SYNDROME	2.6781298400000004	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	56.78368641006591
MYOCLONIC-ASTASTIC EPILEPSY	1.2308145400000001	45.95798611466873
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.57192411552383
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.18037843900802
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.33948911155106
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.33948911155106
MYOCLONIC EPILEPSY OF LAFORA	0.93909192	35.06521252158558
LAFORA DISEASE	0.7746924000000001	28.92661843460136
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.77444881462506
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7480334099999999	27.931185367771405
EARLY MYOCLONIC ENCEPHALOPATHY	0.7128345199999999	26.616876797877726
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6955347199999999	25.97091110414571
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.60217849	22.48503717056526
ROLANDIC EPILEPSY	0.5906213	22.05349760040013
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5636522	21.046485184601803
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	19.969535905697537
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.678918927993422
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.52245151	19.50807246895841
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5150467	19.231580646590306
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.93269857297135
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.50168634	18.732711629843905
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.500541419	18.68996086463082
CREST SYNDROME	0.5	18.66974455577553
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	18.66974455577553
INHALATIONAL ANTHRAX	0.5	18.66974455577553
PAROXYSMAL HEMICRANIA	0.5	18.66974455577553
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.66974455577553
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.66974455577553
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42673753000000003	15.934161354925195
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41923691	15.654092036105313
SPINOCEREBELLAR ATAXIA TYPE 10	0.41057764	15.330759318226331
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.501530291750155
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.612480789953036
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3638483	13.585909636106363
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.349526772757212
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.349526772757212
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.35530065	13.266744752002014
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.3552659	13.26544720475539
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.244350393407364
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.35267945	13.168870483142816
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.35191631999999995	13.140375598817117
MYOCLONIC-ATONIC EPILEPSY	0.3497355	13.058944894172866
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.3497355	13.058944894172866
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.70943794121647
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.3396705	12.683122936265104
OROFACIODIGITAL SYNDROME TYPE 3	0.33798416	12.62015586219673
COG4-CDG	0.3348101	12.501638083387324
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333874419	12.466700232875935
NEUROMYELITIS OPTICA	0.333333	12.446483924020649
EPIDERMAL NEVUS SYNDROME	0.333333	12.446483924020649
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.446483924020649
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32145334999999997	12.00290386219661
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30073585999999997	11.229323369922943
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.26693939999999994	9.96738081974397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25939474	9.685667069823618
HYPEREKPLEXIA 1; HKPX1	0.25465116	9.508544216063846
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25168634	9.397839351956138
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.334872277887765
PALLISTER-HALL SYNDROME	0.25	9.334872277887765
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24249960000000004	9.054811173755489
LENNOX-GASTAUT SYNDROME	0.23722246999999996	8.857765835580246
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.850840480534728
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23406925	8.740026211723924
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.436079036406987
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21946495000000002	8.194709110892099
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21923995000000002	8.186307725842
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.21840821000000002	8.155250979168358
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.467897822310213
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.467897822310213
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.19404291	7.2454631251186825
MYOCLONIC EPILEPSY OF INFANCY	0.19138809999999998	7.146333876030445
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.19138809999999998	7.146333876030445
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.832204222032788
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.18019681999999998	6.728457198326125
UNILATERAL POLYMICROGYRIA	0.17265286000000002	6.446769586048149
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.16988399999999998	6.34338176822674
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16792089999999998	6.270080617151853
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.9558613483803295
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.9558613483803295
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.67994343395987
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15211625999999998	5.67994343395987
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15081698	5.631428982547014
COMBINED SAPOSIN DEFICIENCY	0.14750815999999997	5.50787933418493
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14520145	5.421747961256426
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.14445954	5.394045420889674
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.334207396008849
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.334207396008849
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14265366000000002	5.326614784292907
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.13416504	5.009654050230813
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.129196319	4.824124546552977
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12727819999999998	4.752502963037817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12468059999999999	4.655509906121653
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12180288999999998	4.548057684910451
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11944025	4.459837914355937
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.11924649999999999	4.452603388340573
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11815324999999999	4.41178199186937
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.11710767999999999	4.372740942239005
DYSTONIA 16; DYT16	0.11644697999999999	4.348070741783004
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.222920722917601
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.11165241899999999	4.169044283528836
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.11165241899999999	4.169044283528836
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	4.14882797467355
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.11052365	4.12689662574388
BILATERAL POLYMICROGYRIA	0.10411521	3.887608750141852
AICARDI SYNDROME; AIC	0.1036867	3.871608405662662
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.10113961	3.7765013663415212
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755000000001	3.674487641719417
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6638197496802465
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6638197496802465
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6638197496802465
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6638197496802465
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6638197496802465
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.0978483	3.6536055324337817
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.0978483	3.6536055324337817
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0978483	3.6536055324337817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08897250000000001	3.322187694977477
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.08800626	3.286108787018332
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08693017	3.245928136180283
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0850197	3.1745921624173374
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08123344	3.0332151483738365
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.08102891000000001	3.0255781026658513
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.08096025999999999	3.0230147467383426
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.0803901	3.001725263626501
TUBEROUS SCLEROSIS COMPLEX	0.07794046	2.910256957519281
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.077916479	2.9093615192308966
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8722692548767537
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07607976000000001	2.840779370129418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07573894	2.828053325450419
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.07460524999999998	2.785721920039544
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07413886	2.7683071557128085
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.7259335566792378
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7218101568966495
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.6671074319533363
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.642866635622117
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5095168276083277
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.489300518753041
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.489300518753041
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.489300518753041
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.489300518753041
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.489300518753041
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.489300518753041
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.489300518753041
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.489300518753041
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.489300518753041
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.489300518753041
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0666667	2.489300518753041
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.489300518753041
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.489300518753041
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.489300518753041
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.4753056782340317
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06428419	2.4003388125498795
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.0636522	2.3767406288262705
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.059865940000000006	2.2353636147827696
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.059464249999999996	2.22036471540155
PYRIDOXINE-DEPENDENT EPILEPSY	0.05697231	2.1273169489049115
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	2.0744177212856862
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0744177212856862
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0744177212856862
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0744177212856862
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0744177212856862
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0744177212856862
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0744177212856862
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0744177212856862
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0744177212856862
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0744177212856862
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0744177212856862
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0744177212856862
GITELMAN SYNDROME	0.055555600000000004	2.0744177212856862
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0744177212856862
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0744177212856862
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0744177212856862
MENTAL RETARDATION, X-LINKED 98; MRX98	0.055241379	2.0626848696775655
ALG13-CDG	0.053451639999999995	1.995856929774547
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.053326099999999994	1.991169330311483
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05286995	1.974136922353249
NEURONAL CEROID LIPOFUSCINOSIS	0.051806869	1.934442020929052
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9110768356174992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05073566	1.8944436241373568
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04951706000000001	1.8489417227060208
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04887121	1.8248260136633252
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.812133947919418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0473761	1.7689993700977542
SARCOSINEMIA	0.047187709999999994	1.7619649837440288
MERRF	0.046644099999999994	1.7416668640680988
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04635284	1.7307913644694684
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0453985	1.695156796430751
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.045321700000000006	1.692289123666984
ALPERS-HUTTENLOCHER SYNDROME	0.04525865	1.6899348688785003
AMISH INFANTILE EPILEPSY SYNDROME	0.04504195	1.6818434015880273
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.677495591475878
DOORS SYNDROME	0.04339331	1.6202840262591598
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.043374499999999996	1.6195816704689714
FLYNN-AIRD SYNDROME	0.043259859	1.6153010340977338
MYOCLONUS AND ATAXIA	0.043165260000000004	1.6117687557672706
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.04305249	1.607557981580161
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.043033680000000005	1.6068556257899727
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04292174	1.6026758433788257
ISOLATED CEREBELLAR AGENESIS	0.042823629	1.5990124287626022
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5965077331724888
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.5965077331724888
SALT-AND-PEPPER SYNDROME	0.04186789	1.5633256227786174
ATYPICAL RETT SYNDROME	0.041782758999999996	1.560146874731062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.04172856	1.558123111760705
16P13.11 MICRODELETION SYNDROME	0.0417099	1.5574263568938838
DISTAL MONOSOMY 12Q	0.041666699999999994	1.5558132909642644
COG2-CDG	0.041666699999999994	1.5558132909642644
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.5487075861863364
CANAVAN DISEASE	0.04134734	1.5438885517215997
CHRISTIANSON SYNDROME	0.04134734	1.5438885517215997
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.041346529	1.5438582693959302
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.041346529	1.5438582693959302
HUNTINGTON DISEASE	0.04124134	1.5399305658757754
WEST SYNDROME	0.041219599999999995	1.53911880538249
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.04080511	1.5236419605406433
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.04073161	1.5208975080909444
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.04068664	1.519218351265598
JUVENILE ABSENCE EPILEPSY	0.04031741	1.5054314917009397
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03947121	1.4738348160147452
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4674549909051455
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.4674549909051455
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.03874215	1.446612088083078
MCLEOD SYNDROME; MCLDS	0.03872334	1.4459097322928898
TRICHOTHIODYSTROPHY	0.03872334	1.4459097322928898
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.03872334	1.4459097322928898
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.038586959	1.440817335428367
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4383656619127918
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0384081	1.4341388317453643
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03837959	1.4330742829107939
LEIGH SYNDROME	0.037926259	1.4161471349723653
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4145415742800576
MENINGIOMA	0.03780191	1.411504006840833
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03735259	1.394726627593231
LISSENCEPHALY 2; LIS2	0.037037	1.3829426582245166
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3829426582245166
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3829426582245166
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3829426582245166
AICARDI SYNDROME	0.036931	1.3789846723786923
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03676104	1.372638452809293
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.036449158999999995	1.360992975605693
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.035714300000000004	1.3335537159766682
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03566625	1.3317595535248579
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3317595535248579
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3317595535248579
WOLF-HIRSCHHORN SYNDROME	0.034276618999999994	1.279871441931284
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.034276618999999994	1.279871441931284
GRISCELLI SYNDROME TYPE 1	0.034276618999999994	1.279871441931284
SANDHOFF DISEASE	0.034276618999999994	1.279871441931284
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03394444	1.2674680477776983
YOU-HOOVER-FONG SYNDROME; YHFS	0.0337352	1.2596551330759975
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0337352	1.2596551330759975
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0337352	1.2596551330759975
OXOGLUTARIC ACIDURIA	0.0337352	1.2596551330759975
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.033437259999999996	1.2485302056901018
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.033437259999999996	1.2485302056901018
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.033348539999999996	1.2452174462161247
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2247172825646122
TUBEROUS SCLEROSIS-1	0.032799519	1.2247172825646122
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2247172825646122
CHROMOSOME 1P36 DELETION SYNDROME	0.032799519	1.2247172825646122
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2247172825646122
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2247172825646122
3P25.3 MICRODELETION SYNDROME	0.03270401	1.221151025299057
DIENCEPHALIC SYNDROME	0.0322581	1.204500973709325
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.204500973709325
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.204500973709325
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.204500973709325
SLC35A2-CDG	0.0322581	1.204500973709325
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.204500973709325
LESCH-NYHAN SYNDROME	0.0322581	1.204500973709325
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.204500973709325
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0322581	1.204500973709325
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.204500973709325
PEHO SYNDROME	0.0322581	1.204500973709325
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.03142744	1.1734845536839242
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.165996865932385
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.030676639999999998	1.1454500652589716
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.029782249999999996	1.1120539995924914
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.02971506	1.1095451593190866
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.029272909999999996	1.0930355042084139
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.029254759	1.0923577551415504
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.0890218451843243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0290382	1.084271552719042
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0688055363290374
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0688055363290374
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02837791	1.059616661453576
EPILEPSY, PYRIDOXINE-DEPENDENT	0.027795809999999997	1.037881344841742
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0372088606428431
GANGLIOCYTOMA	0.027777800000000002	1.0372088606428431
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0372088606428431
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0372088606428431
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0372088606428431
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0372088606428431
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.02749805	1.0267631385638865
RETT SYNDROME, CONGENITAL VARIANT	0.027068559000000002	1.0107261640458776
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0091743722178905
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0091743722178905
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0091743722178905
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0091743722178905
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0091743722178905
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.026288650000000004	0.981604760432377
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.02600856	0.9711463429271224
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02562557	0.9568456919922896
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.02543126	0.949590255863024
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02489579	0.9295960796284619
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.02458615	0.9180342802199611
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.0244991	0.9147838776928007
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.024495579000000003	0.9146524053516389
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.0239818	0.8954681599753952
2Q23.1 MICRODUPLICATION SYNDROME	0.023954160000000002	0.894436096496352
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023954160000000002	0.894436096496352
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.023872759	0.8913966247431826
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.02333134	0.8711803158878958
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.022758219000000003	0.8497802705487947
POTOCKI-LUPSKI SYNDROME	0.022758219000000003	0.8497802705487947
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.022736479	0.8489685100555094
ADENYLOSUCCINASE DEFICIENCY	0.022736479	0.8489685100555094
CEREBROTENDINOUS XANTHOMATOSIS	0.022722829	0.8484588260291366
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.02247917	0.8393607234517052
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02221795	0.8296069021059859
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0222149	0.8294930166641956
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0222149	0.8294930166641956
GAUCHER DISEASE	0.022088950000000003	0.8247901080105958
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8202608279813647
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8202608279813647
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.021932899999999998	0.8189632807347382
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.02133566	0.7966626442577556
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02097441	0.7831737538162076
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7744527427393137
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7744527427393137
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7744527427393137
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.020511679999999997	0.7658956520196196
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0204558	0.7638091213680661
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.0204558	0.7638091213680661
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.02010886	0.7508545590157046
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.02010886	0.7508545590157046
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.02010886	0.7508545590157046
FUMARASE DEFICIENCY; FMRD	0.02004131	0.7483322765262194
BETA-UREIDOPROPIONASE DEFICIENCY	0.02004131	0.7483322765262194
SIALIDOSIS TYPE 1	0.019889589	0.7426670918987257
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.019771659000000004	0.7382636459478007
11Q22.2Q22.3 MICRODELETION SYNDROME	0.019771659000000004	0.7382636459478007
MENTAL RETARDATION, X-LINKED 104; MRX104	0.019562419	0.7304507312460996
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.019562419	0.7304507312460996
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.019235739999999998	0.7182527042826271
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019230240000000003	0.7180473370925138
MELAS	0.01918893	0.7165048427973154
ISOLATED COMPLEX I DEFICIENCY	0.019021	0.7102344223908127
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6921453068907217
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.018412489	0.6875129325320537
AYMÉ-GRIPP SYNDROME	0.0183715	0.6859824242128603
CARNOSINASE DEFICIENCY	0.018242500000000002	0.6811656301174702
HYPERPROLINEMIA, TYPE I	0.018185719	0.6790454565862273
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.018085319000000002	0.6752965718794276
FRAGILE X MENTAL RETARDATION SYNDROME	0.018085319000000002	0.6752965718794276
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018085319000000002	0.6752965718794276
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.018085319000000002	0.6752965718794276
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.018085319000000002	0.6752965718794276
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.018085319000000002	0.6752965718794276
HEART AND BRAIN MALFORMATION SYNDROME	0.018085319000000002	0.6752965718794276
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018085319000000002	0.6752965718794276
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.018085319000000002	0.6752965718794276
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.018085319000000002	0.6752965718794276
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.018085319000000002	0.6752965718794276
PHELAN-MCDERMID SYNDROME	0.018085319000000002	0.6752965718794276
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018085319000000002	0.6752965718794276
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.018085319000000002	0.6752965718794276
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018085319000000002	0.6752965718794276
8Q24.3 MICRODELETION SYNDROME	0.018085319000000002	0.6752965718794276
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.018085319000000002	0.6752965718794276
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.018071669000000002	0.674786887853055
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.018032399	0.6733205661156443
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018008939999999998	0.6724446190405763
RING CHROMOSOME 14 SYNDROME	0.01790456	0.6685471231671127
PERMANENT NEONATAL DIABETES MELLITUS	0.01777861	0.6638442145135128
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.017644299999999998	0.6588291477309404
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0175439	0.6550802630241407
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.0175439	0.6550802630241407
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.0175439	0.6550802630241407
MUSCLE-EYE-BRAIN DISEASE	0.017410969000000002	0.6501166873970532
COG8-CDG	0.017390278999999998	0.649344133367335
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6437850675678964
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6437850675678964
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6437850675678964
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6437850675678964
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6437850675678964
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6437850675678964
MYOPATHY, CONGENITAL	0.0172414	0.6437850675678964
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6437850675678964
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6437850675678964
ERYTHERMALGIA, PRIMARY	0.0172414	0.6437850675678964
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6437850675678964
269800 SENILE PLAQUE FORMATION	0.0172414	0.6437850675678964
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6437850675678964
THUMBS, CONGENITAL CLASPED	0.0172414	0.6437850675678964
MOTION SICKNESS	0.0172414	0.6437850675678964
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6437850675678964
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6437850675678964
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6437850675678964
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6437850675678964
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6437850675678964
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6437850675678964
RHEUMATOID ARTHRITIS	0.0172414	0.6437850675678964
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6437850675678964
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6437850675678964
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6437850675678964
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6437850675678964
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6437850675678964
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6437850675678964
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6437850675678964
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6437850675678964
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6437850675678964
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6437850675678964
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6437850675678964
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6437850675678964
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6437850675678964
CARDIAC ARRHYTHMIA	0.0172414	0.6437850675678964
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6437850675678964
MOSAIC TRISOMY 15	0.0172414	0.6437850675678964
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6437850675678964
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6437850675678964
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6437850675678964
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6437850675678964
CERVICAL RIB	0.0172414	0.6437850675678964
SICKLE CELL ANEMIA	0.0172414	0.6437850675678964
PALMOMENTAL REFLEX	0.0172414	0.6437850675678964
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6437850675678964
TRANSSEXUALITY	0.0172414	0.6437850675678964
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6437850675678964
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6437850675678964
ALCOHOL DEPENDENCE	0.0172414	0.6437850675678964
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6437850675678964
DIASTEMATOMYELIA	0.0172414	0.6437850675678964
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6437850675678964
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6437850675678964
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.017048409	0.6365788822247692
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6124609701522161
HAREL-YOON SYNDROME; HAYOS	0.016402499999999997	0.6124609701522161
NIEMANN-PICK DISEASE TYPE B	0.016402499999999997	0.6124609701522161
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6086900551468407
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6086900551468407
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6086900551468407
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.01614546	0.6028632278709832
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.01614546	0.6028632278709832
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01614546	0.6028632278709832
PEHO-LIKE SYNDROME; PEHOL	0.01614546	0.6028632278709832
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.01614546	0.6028632278709832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01614546	0.6028632278709832
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015928939	0.594778444349061
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.015928939	0.594778444349061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.01580464	0.5901371831919843
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.5901371831919843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.015717118999999998	0.5868691937654522
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.015652918999999998	0.5844719985644906
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.015652918999999998	0.5844719985644906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.0156185	0.5831868106887602
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.01559676	0.5823750501954751
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.015588119000000001	0.5820523996700623
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01538752	0.5745621354937742
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.015384939999999998	0.5744657996118663
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.015384939999999998	0.5744657996118663
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.015238429000000001	0.568995153722644
CENTRAL BILATERAL MACROGYRIA	0.015238429000000001	0.568995153722644
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.015238429000000001	0.568995153722644
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.015175699999999999	0.5666528849101654
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5666528849101654
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5573068107855441
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.014925399999999998	0.5573068107855441
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.014925399999999998	0.5573068107855441
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5573068107855441
METACHROMATIC LEUKODYSTROPHY	0.014875869000000002	0.55545734855036
PELIZAEUS-MERZBACHER DISEASE	0.014875869000000002	0.55545734855036
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.014788019	0.5521770744319101
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.014657739999999999	0.5473125231299464
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.014657739999999999	0.5473125231299464
XERODERMA PIGMENTOSUM	0.014651398999999999	0.5470757534294901
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013932159999999999	0.5202197366203871
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01391042	0.5194079761271021
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.01391042	0.5194079761271021
FOUNTAIN SYNDROME	0.013761329000000001	0.5138409943559719
ZLOTOGORA-OGUR SYNDROME	0.013761329	0.5138409943559719
SMITH-MAGENIS SYNDROME	0.013761329	0.5138409943559719
ARGININEMIA	0.013761329	0.5138409943559719
ISOLATED GLYCEROL KINASE DEFICIENCY	0.013761329	0.5138409943559719
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.013698599999999998	0.5114987255434933
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5114987255434933
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5114987255434933
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013698599999999998	0.5114987255434933
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5114987255434933
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5114987255434933
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5114987255434933
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5114987255434933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.5114987255434933
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5114987255434933
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5114987255434933
19P13.3 MICRODUPLICATION SYNDROME	0.013698599999999998	0.5114987255434933
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5114987255434933
OLIVER SYNDROME	0.01345251	0.5023098506680318
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01345251	0.5023098506680318
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.01345251	0.5023098506680318
ADNP SYNDROME	0.013398769000000001	0.5003031891836879
NASU-HAKOLA DISEASE	0.013398769000000001	0.5003031891836879
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.013310919000000001	0.49702291506523816
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.013310919000000001	0.49702291506523816
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.013219910000000001	0.493624685500685
CANAVAN DISEASE	0.013174299	0.49192159406281805
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01317051	0.49178011473857436
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0129714	0.48434544906157345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0129714	0.48434544906157345
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.012948359	0.4834851098929542
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012908900000000001	0.48201173099210154
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.012739119	0.47567219519125326
TRISOMY 13	0.012738069000000001	0.47563298872768617
WORSTER-DROUGHT SYNDROME	0.012738069000000001	0.47563298872768617
ALEXANDER DISEASE	0.012688099000000001	0.4737671344567819
HSD10 DISEASE	0.012666358999999999	0.4729553739634967
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.012234829	0.4568422642271891
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01219665	0.45541667987239925
TRISOMY 20P	0.01219665	0.45541667987239925
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.01219665	0.45541667987239925
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.01219665	0.45541667987239925
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.012078419	0.4510019947352515
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.01174624	0.4385986005816655
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01171515	0.4374377158651874
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.01171515	0.4374377158651874
ATAXIA-PANCYTOPENIA SYNDROME	0.01171045	0.43726222026636313
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.01169341	0.4366259553719023
MYOCLONIC EPILEPSY, JUVENILE, 2	0.01169341	0.4366259553719023
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.01169341	0.4366259553719023
NIEMANN-PICK DISEASE TYPE C	0.011664839000000001	0.43555912882849623
1P36 DELETION SYNDROME	0.011624579	0.43405584099686506
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.011602839	0.43324408050358
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.011602839	0.43324408050358
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.42919128969490133
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.011494299999999999	0.42919128969490133
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.011494299999999999	0.42919128969490133
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.42919128969490133
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.42919128969490133
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.011494299999999999	0.42919128969490133
WRINKLY SKIN SYNDROME	0.011494299999999999	0.42919128969490133
DESMOSTEROLOSIS	0.011494299999999999	0.42919128969490133
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.42919128969490133
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.011494299999999999	0.42919128969490133
PERLMAN SYNDROME	0.011494299999999999	0.42919128969490133
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.011494299999999999	0.42919128969490133
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.011494299999999999	0.42919128969490133
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.011494299999999999	0.42919128969490133
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.42919128969490133
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.011342579	0.42352610506740773
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.011342579	0.42352610506740773
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.011342579	0.42352610506740773
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.011262019000000002	0.42051803582458125
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.011262019000000002	0.42051803582458125
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.011262019000000002	0.42051803582458125
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.011210999	0.41861297509010975
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.011189258999999998	0.4178012145968246
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.01112342	0.41534281997320927
RETT SYNDROME	0.011001759	0.4108000603884089
TAY-SACHS DISEASE	0.011001759	0.4108000603884089
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.011001759	0.4108000603884089
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.010980018999999999	0.4099882998951237
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.010980018999999999	0.4099882998951237
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.010980018999999999	0.4099882998951237
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.010980018999999999	0.4099882998951237
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010980018999999999	0.4099882998951237
WHIPPLE DISEASE	0.010980018999999999	0.4099882998951237
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0109456	0.40870311201939324
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.01073636	0.4008901973176923
GAUCHER DISEASE TYPE 3	0.01073636	0.4008901973176923
BIOTINIDASE DEFICIENCY	0.01073636	0.4008901973176923
KRABBE DISEASE	0.01073636	0.4008901973176923
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.0107206	0.40030172696929434
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.01064784	0.3975849057415379
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.010601319000000001	0.3958478353685795
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010601319000000001	0.3958478353685795
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.010601319000000001	0.3958478353685795
CORNELIA DE LANGE SYNDROME 3	0.010601319000000001	0.3958478353685795
NEUROFIBROMATOSIS TYPE 1	0.010565529	0.394511455053277
TYROSINEMIA TYPE 2	0.010565529	0.394511455053277
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.010565529	0.394511455053277
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.010565529	0.394511455053277
DYSTONIA-APHONIA SYNDROME	0.010528558999999998	0.39313101414082285
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.010528558999999998	0.39313101414082285
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.010438600000000001	0.38977199103983695
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.010438600000000001	0.38977199103983695
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.010341059000000001	0.38612985993240717
SYMMETRICAL THALAMIC CALCIFICATIONS	0.010341059	0.38612985993240706
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.010115119	0.37769337576254325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.010115119	0.37769337576254325
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.010024110000000001	0.37429514619799015
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.010024110000000001	0.37429514619799015
CAMURATI-ENGELMANN DISEASE	0.010024110000000001	0.37429514619799015
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.010024110000000001	0.37429514619799015
PENDRED SYNDROME	0.010024110000000001	0.37429514619799015
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.010024110000000001	0.37429514619799015
VON HIPPEL-LINDAU DISEASE	0.010024110000000001	0.37429514619799015
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.010024110000000001	0.37429514619799015
BARDET-BIEDL SYNDROME 1; BBS1	0.010024110000000001	0.37429514619799015
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.010024110000000001	0.37429514619799015
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.009987139999999999	0.372914705285536
SPINOCEREBELLAR ATAXIA TYPE 14	0.009987139999999999	0.372914705285536
DYSTONIA 28, CHILDHOOD-ONSET	0.009987139999999999	0.372914705285536
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.009978499	0.37259205476012314
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.009865479	0.3683719457007356
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.009865479	0.3683719457007356
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.009865479	0.3683719457007356
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.009865479	0.3683719457007356
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.009865479	0.3683719457007356
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00979964	0.3659135510771202
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0097779	0.36510179058383513
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.009573700000000001	0.35747706690725645
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0095737	0.35747706690725634
NORRIE DISEASE	0.009524659000000001	0.3556459010217369
RETT SYNDROME; RTT	0.009524659000000001	0.3556459010217369
NEONATAL ADRENOLEUKODYSTROPHY	0.009524659000000001	0.3556459010217369
CADASIL	0.009524659000000001	0.3556459010217369
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.009524659000000001	0.3556459010217369
KRABBE DISEASE	0.009524659000000001	0.3556459010217369
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.009524659000000001	0.3556459010217369
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.009524659000000001	0.3556459010217369
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.009502918999999999	0.35483414052845164
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.009502918999999999	0.35483414052845164
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.009502918999999999	0.35483414052845164
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.009502918999999999	0.35483414052845164
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.009502918999999999	0.35483414052845164
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.009502918999999999	0.35483414052845164
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.009502918999999999	0.35483414052845164
SCHINDLER DISEASE, TYPE I	0.009502918999999999	0.35483414052845164
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00943708	0.3523757459048363
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00925926	0.34573603795102026
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.34573603795102026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.34573603795102026
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00925926	0.34573603795102026
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.34573603795102026
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34573603795102026
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34573603795102026
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.34573603795102026
GLYCINE ENCEPHALOPATHY	0.00925926	0.34573603795102026
GAUCHER DISEASE TYPE 2	0.00925926	0.34573603795102026
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.34573603795102026
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.34573603795102026
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00925926	0.34573603795102026
CARNOSINEMIA	0.00925926	0.34573603795102026
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34573603795102026
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34573603795102026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.34573603795102026
HYDROXYLYSINURIA	0.00925926	0.34573603795102026
PAINE SYNDROME	0.00925926	0.34573603795102026
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34573603795102026
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.34573603795102026
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.34573603795102026
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34573603795102026
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.009088429	0.3393572956866049
MICROPHTHALMIA, LENZ TYPE	0.009088429	0.3393572956866049
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.009088429	0.3393572956866049
DDOST-CDG	0.009088429	0.3393572956866049
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009088429	0.3393572956866049
CORNELIA DE LANGE SYNDROME	0.009088429	0.3393572956866049
COFFIN-LOWRY SYNDROME	0.009088429	0.3393572956866049
STURGE-WEBER SYNDROME	0.009088429	0.3393572956866049
TAKAYASU ARTERITIS	0.009088429	0.3393572956866049
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.009088429	0.3393572956866049
WHIM SYNDROME	0.009088429	0.3393572956866049
22Q11.2 MICRODUPLICATION SYNDROME	0.009088429	0.3393572956866049
COHEN SYNDROME	0.009088429	0.3393572956866049
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.009088429	0.3393572956866049
ASPARTYLGLUCOSAMINURIA	0.009088429	0.3393572956866049
CONGENITAL RUBELLA SYNDROME	0.009088429	0.3393572956866049
FRAGILE X SYNDROME	0.009088429	0.3393572956866049
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.009088429	0.3393572956866049
SIMPSON-GOLABI-BEHMEL SYNDROME	0.009088429	0.3393572956866049
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008863959000000001	0.3309757005657351
GALLOWAY-MOWAT SYNDROME	0.008863959000000001	0.3309757005657351
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.008863959000000001	0.3309757005657351
PHAKOMATOSIS PIGMENTOVASCULARIS	0.008863959000000001	0.3309757005657351
ZELLWEGER SYNDROME	0.008863959000000001	0.3309757005657351
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00872859	0.32592109126419344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00872859	0.32592109126419344
WAISMAN SYNDROME; WSMN	0.008638019	0.3225392163958712
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.008638019	0.3225392163958712
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.008638019	0.3225392163958712
POSTENCEPHALITIC PARKINSONISM	0.008638019	0.3225392163958712
TOLUENE EMBRYOPATHY	0.00854701	0.31914098683131803
PSYCHOGENIC MOVEMENT DISORDERS	0.00854701	0.31914098683131803
PRIMARY PROGRESSIVE FREEZING GAIT	0.00854701	0.31914098683131803
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00854701	0.31914098683131803
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00854701	0.31914098683131803
ALZHEIMER DISEASE 10	0.00854701	0.31914098683131803
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00854701	0.31914098683131803
GOLDENHAR SYNDROME	0.00854701	0.31914098683131803
TRISOMY XQ28	0.00854701	0.31914098683131803
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00854701	0.31914098683131803
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00854701	0.31914098683131803
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00854701	0.31914098683131803
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00854701	0.31914098683131803
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00854701	0.31914098683131803
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00854701	0.31914098683131803
HISTIDINEMIA	0.00854701	0.31914098683131803
BARDET-BIEDL SYNDROME	0.00854701	0.31914098683131803
HISTIDINEMIA	0.00854701	0.31914098683131803
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.00854701	0.31914098683131803
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00854701	0.31914098683131803
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00854701	0.31914098683131803
ALOPECIA ANTIBODY DEFICIENCY	0.00854701	0.31914098683131803
3C SYNDROME	0.00854701	0.31914098683131803
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00854701	0.31914098683131803
15Q26 OVERGROWTH SYNDROME	0.00854701	0.31914098683131803
RECESSIVE X-LINKED ICHTHYOSIS	0.00854701	0.31914098683131803
OTOFACIOCERVICAL SYNDROME	0.00854701	0.31914098683131803
BRANCHIO-OCULO-FACIAL SYNDROME	0.00854701	0.31914098683131803
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00854701	0.31914098683131803
FLOATING-HARBOR SYNDROME	0.00854701	0.31914098683131803
FREEMAN-SHELDON SYNDROME	0.00854701	0.31914098683131803
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.00854701	0.31914098683131803
ALBINISM-DEAFNESS SYNDROME	0.00854701	0.31914098683131803
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00854701	0.31914098683131803
BECKWITH-WIEDEMANN SYNDROME	0.00854701	0.31914098683131803
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.31914098683131803
GERMAN SYNDROME	0.00854701	0.31914098683131803
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00854701	0.31914098683131803
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00854701	0.31914098683131803
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00854701	0.31914098683131803
NEURALGIC AMYOTROPHY	0.00854701	0.31914098683131803
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00854701	0.31914098683131803
SHORT SYNDROME	0.00854701	0.31914098683131803
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00854701	0.31914098683131803
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00851935	0.3181081765624926
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.008501399	0.3174378953934511
GM2 GANGLIOSIDOSIS, AB VARIANT	0.008501399	0.3174378953934511
FABRY DISEASE	0.008501399	0.3174378953934511
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.008428779	0.31472630169417026
DISTAL MONOSOMY 10Q	0.008428779	0.31472630169417026
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.008428779	0.31472630169417026
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.008428779	0.31472630169417026
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.008428779	0.31472630169417026
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.008428779	0.31472630169417026
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.008377759	0.31282124095969893
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.008356019	0.31200948046641375
EARLY-ONSET LAFORA BODY DISEASE	0.008356019	0.31200948046641375
KUFOR-RAKEB SYNDROME	0.008356019	0.31200948046641375
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.008356019	0.31200948046641375
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.008356019	0.31200948046641375
CARTILAGE-HAIR HYPOPLASIA	0.00832254	0.31075939171044814
CHILDHOOD APRAXIA OF SPEECH	0.0080966	0.30232290754058433
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0080966	0.30232290754058433
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0080966	0.30232290754058433
CHOREOACANTHOCYTOSIS	0.008015199	0.29928343578741495
WOLFRAM SYNDROME	0.008015199	0.29928343578741495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.008015199	0.29928343578741495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.008015199	0.29928343578741495
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00788736	0.29450999283888335
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00788736	0.29450999283888335
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0078146	0.2917931716111269
BRAIN-LUNG-THYROID SYNDROME	0.0078146	0.2917931716111269
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0078146	0.2917931716111269
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2831703260511073
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.007473779999999999	0.2790671269321281
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.007473779999999999	0.2790671269321281
ATAXIA-TELANGIECTASIA	0.0073544990000000005	0.2746132353314132
GALACTOSEMIA	0.0073544990000000005	0.2746132353314132
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0073544990000000005	0.2746132353314132
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26295401719582046
1Q44 MICRODELETION SYNDROME	0.00704225	0.26295401719582046
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26295401719582046
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26295401719582046
W SYNDROME	0.00704225	0.26295401719582046
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.26295401719582046
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26295401719582046
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26295401719582046
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.26295401719582046
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26295401719582046
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26295401719582046
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.26295401719582046
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26295401719582046
PELGER-HUET ANOMALY; PHA	0.00704225	0.26295401719582046
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26295401719582046
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26295401719582046
X SMALL RINGS	0.00704225	0.26295401719582046
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26295401719582046
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26295401719582046
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26295401719582046
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26295401719582046
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00704225	0.26295401719582046
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26295401719582046
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26295401719582046
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26295401719582046
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00704225	0.26295401719582046
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26295401719582046
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26295401719582046
AMISH LETHAL MICROCEPHALY	0.00704225	0.26295401719582046
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26295401719582046
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26295401719582046
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0069516790000000005	0.2595721423274982
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0069516790000000005	0.2595721423274982
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0069516790000000005	0.2595721423274982
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0069516790000000005	0.2595721423274982
21Q22.11Q22.12 MICRODELETION SYNDROME	0.0069516790000000005	0.2595721423274982
MENTAL RETARDATION, X-LINKED 100	0.0069516790000000005	0.2595721423274982
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.0069516790000000005	0.2595721423274982
KOOLEN-DE VRIES SYNDROME; KDVS	0.0069516790000000005	0.2595721423274982
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.0069516790000000005	0.2595721423274982
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0069516790000000005	0.2595721423274982
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0069516790000000005	0.2595721423274982
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0069516790000000005	0.2595721423274982
MAN1B1-CDG	0.0069516790000000005	0.2595721423274982
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.0069516790000000005	0.2595721423274982
WILSON-TURNER SYNDROME	0.0069516790000000005	0.2595721423274982
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0069516790000000005	0.2595721423274982
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.0069516790000000005	0.2595721423274982
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0069516790000000005	0.2595721423274982
MENTAL RETARDATION, X-LINKED 1	0.0069516790000000005	0.2595721423274982
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0069516790000000005	0.2595721423274982
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0069516790000000005	0.2595721423274982
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0069516790000000005	0.2595721423274982
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.0069516790000000005	0.2595721423274982
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.0069516790000000005	0.2595721423274982
KOOLEN-DE VRIES SYNDROME	0.0069516790000000005	0.2595721423274982
SLC39A8-CDG	0.0069516790000000005	0.2595721423274982
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0069516790000000005	0.2595721423274982
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0069516790000000005	0.2595721423274982
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0069516790000000005	0.2595721423274982
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0069516790000000005	0.2595721423274982
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0069516790000000005	0.2595721423274982
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.0069516790000000005	0.2595721423274982
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0069516790000000005	0.2595721423274982
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0069516790000000005	0.2595721423274982
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0069516790000000005	0.2595721423274982
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0069516790000000005	0.2595721423274982
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.0069516790000000005	0.2595721423274982
8P23.1 MICRODELETION SYNDROME	0.0069516790000000005	0.2595721423274982
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.0069516790000000005	0.2595721423274982
MENTAL RETARDATION, X-LINKED 14	0.0069516790000000005	0.2595721423274982
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0069516790000000005	0.2595721423274982
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0069516790000000005	0.2595721423274982
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0069516790000000005	0.2595721423274982
PITT-HOPKINS-LIKE SYNDROME	0.0069516790000000005	0.2595721423274982
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0069516790000000005	0.2595721423274982
MEHMO SYNDROME; MEHMO	0.0069516790000000005	0.2595721423274982
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0069516790000000005	0.2595721423274982
PARTINGTON SYNDROME	0.006900659	0.2576670815930268
HUNTINGTON DISEASE-LIKE 1	0.006900659	0.2576670815930268
SUPRABULBAR PARESIS, CONGENITAL	0.006900659	0.2576670815930268
ADULT-ONSET DYSTONIA-PARKINSONISM	0.006878918999999999	0.2568553210997417
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.006878918999999999	0.2568553210997417
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.006878918999999999	0.2568553210997417
ALZHEIMER DISEASE 3; AD	0.006878918999999999	0.2568553210997417
SPINOCEREBELLAR ATAXIA TYPE 13	0.006878918999999999	0.2568553210997417
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.006878918999999999	0.2568553210997417
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.006878918999999999	0.2568553210997417
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.006878918999999999	0.2568553210997417
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00681308	0.2543969264761263
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00681308	0.2543969264761263
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.006813079999999999	0.2543969264761263
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.006813079999999999	0.2543969264761263
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.006813079999999999	0.2543969264761263
IMMUNODEFICIENCY 23; IMD23	0.006813079999999999	0.2543969264761263
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0066914190000000005	0.2498541668913259
ANGELMAN SYNDROME	0.0066914190000000005	0.2498541668913259
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0066914190000000005	0.2498541668913259
COCKAYNE SYNDROME	0.0066914190000000005	0.2498541668913259
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.006691419	0.2498541668913259
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.006691419	0.2498541668913259
BANGSTAD SYNDROME	0.006691419	0.2498541668913259
MILLER-DIEKER SYNDROME	0.006691419	0.2498541668913259
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.006691419	0.2498541668913259
HARTNUP DISEASE	0.006691419	0.2498541668913259
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.006691419	0.2498541668913259
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.0066696789999999995	0.24904240639804076
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.0066696789999999995	0.24904240639804076
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.0066696789999999995	0.24904240639804076
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.0066696789999999995	0.24904240639804076
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0066696789999999995	0.24904240639804076
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.0066696789999999995	0.24904240639804076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0066696789999999995	0.24904240639804076
THYROCEREBRORETINAL SYNDROME	0.0066696789999999995	0.24904240639804076
HEREDITARY HYPEREKPLEXIA	0.0066696789999999995	0.24904240639804076
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0066696789999999995	0.24904240639804076
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.0066696789999999995	0.24904240639804076
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0066696789999999995	0.24904240639804076
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.006538099	0.2441292764207429
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.006538099	0.2441292764207429
LYNCH SYNDROME	0.006538099	0.2441292764207429
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.006538099	0.2441292764207429
FAMILIAL COLORECTAL CANCER TYPE X	0.006538099	0.2441292764207429
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006538099	0.2441292764207429
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.006538099	0.2441292764207429
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.006538099	0.2441292764207429
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.006538099	0.2441292764207429
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.006538099	0.2441292764207429
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.006538099	0.2441292764207429
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.006538099	0.2441292764207429
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00641026	0.2393558334722113
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.00641026	0.2393558334722113
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00641026	0.2393558334722113
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00641026	0.2393558334722113
AU-KLINE SYNDROME; AUKS	0.00641026	0.2393558334722113
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00641026	0.2393558334722113
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00641026	0.2393558334722113
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00641026	0.2393558334722113
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00641026	0.2393558334722113
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00641026	0.2393558334722113
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.00641026	0.2393558334722113
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00641026	0.2393558334722113
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00641026	0.2393558334722113
TRIGEMINAL NEURALGIA	0.00641026	0.2393558334722113
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00641026	0.2393558334722113
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00641026	0.2393558334722113
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.00641026	0.2393558334722113
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00641026	0.2393558334722113
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00641026	0.2393558334722113
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00641026	0.2393558334722113
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00641026	0.2393558334722113
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.00641026	0.2393558334722113
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00641026	0.2393558334722113
ALAZAMI-YUAN SYNDROME	0.00641026	0.2393558334722113
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.00641026	0.2393558334722113
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.00641026	0.2393558334722113
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00641026	0.2393558334722113
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00641026	0.2393558334722113
SOTOS SYNDROME 3	0.00641026	0.2393558334722113
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.00641026	0.2393558334722113
FRIED SYNDROME	0.00641026	0.2393558334722113
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00641026	0.2393558334722113
17P11.2 MICRODUPLICATION SYNDROME	0.0063592399999999995	0.23745077273773993
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0063592399999999995	0.23745077273773993
CARDIOFACIOCUTANEOUS SYNDROME	0.0063592399999999995	0.23745077273773993
2P15P16.1 MICRODELETION SYNDROME	0.0063592399999999995	0.23745077273773993
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.006337499999999999	0.23663901224445483
DYSTONIA 6, TORSION	0.006337499999999999	0.23663901224445483
DYSTONIA 26, MYOCLONIC; DYT26	0.006337499999999999	0.23663901224445483
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.006337499999999999	0.23663901224445483
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.006337499999999999	0.23663901224445483
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.006337499999999999	0.23663901224445483
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.006337499999999999	0.23663901224445483
SPINOCEREBELLAR ATAXIA 2; SCA2	0.006337499999999999	0.23663901224445483
KUFOR-RAKEB SYNDROME	0.006337499999999999	0.23663901224445483
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.006337499999999999	0.23663901224445483
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006328859000000001	0.23631636171904197
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006328859000000001	0.23631636171904197
MUCOPOLYSACCHARIDOSIS TYPE 3	0.006328859000000001	0.23631636171904197
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.006328859000000001	0.23631636171904197
ETHYLMALONIC ENCEPHALOPATHY	0.006328859000000001	0.23631636171904197
ALEXANDER DISEASE	0.006328859000000001	0.23631636171904197
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.006328859000000001	0.23631636171904197
BEHÇET DISEASE	0.006328859000000001	0.23631636171904197
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.006328859000000001	0.23631636171904197
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.006328859000000001	0.23631636171904197
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006328859000000001	0.23631636171904197
DILATED CARDIOMYOPATHY WITH ATAXIA	0.006328859000000001	0.23631636171904197
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.006328859000000001	0.23631636171904197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.006328859000000001	0.23631636171904197
TRIPLE A SYNDROME	0.006328859000000001	0.23631636171904197
CHÉDIAK-HIGASHI SYNDROME	0.006328859000000001	0.23631636171904197
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.006328859000000001	0.23631636171904197
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.006328859000000001	0.23631636171904197
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.006328859000000001	0.23631636171904197
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.006149999999999999	0.22963785803603898
MUCOLIPIDOSIS TYPE IV	0.006149999999999999	0.22963785803603898
ARGININOSUCCINIC ACIDURIA	0.006149999999999999	0.22963785803603898
BAKER-GORDON SYNDROME; BAGOS	0.006149999999999999	0.22963785803603898
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.00612826	0.2288260975427539
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.00612826	0.2288260975427539
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00612826	0.2288260975427539
POLYMYOCLONUS, INFANTILE	0.00612826	0.2288260975427539
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00612826	0.2288260975427539
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00612826	0.2288260975427539
CEREBELLOPARENCHYMAL DISORDER V	0.00612826	0.2288260975427539
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00612826	0.2288260975427539
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00599668	0.223912967565456
ATAXIA WITH VITAMIN E DEFICIENCY	0.00599668	0.223912967565456
WILLIAMS SYNDROME	0.00599668	0.223912967565456
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.005877399	0.21945907596474112
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005877399	0.21945907596474112
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.005877399	0.21945907596474112
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.005877399	0.21945907596474112
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005877399	0.21945907596474112
REFSUM DISEASE	0.00578744	0.21610005286375505
NEUROFERRITINOPATHY	0.00578744	0.21610005286375505
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.005668159000000001	0.21164616126304017
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.005668159000000001	0.21164616126304017
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.005668159000000001	0.21164616126304017
CYCLIC VOMITING SYNDROME	0.005668159000000001	0.21164616126304017
COWDEN SYNDROME	0.005668159000000001	0.21164616126304017
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005668159000000001	0.21164616126304017
SPINOCEREBELLAR ATAXIA 1	0.00533598	0.1992427671094542
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00533598	0.1992427671094542
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00533598	0.1992427671094542
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.00533598	0.1992427671094542
SUSAC SYNDROME	0.00533598	0.1992427671094542
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00533598	0.1992427671094542
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00533598	0.1992427671094542
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00533598	0.1992427671094542
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00533598	0.1992427671094542
SPINOCEREBELLAR ATAXIA 42	0.00533598	0.1992427671094542
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00533598	0.1992427671094542
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00533598	0.1992427671094542
SPINOCEREBELLAR ATAXIA TYPE 29	0.00533598	0.1992427671094542
SPINOCEREBELLAR ATAXIA 5; SCA5	0.00533598	0.1992427671094542
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00533598	0.1992427671094542
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.00533598	0.1992427671094542
SPINOCEREBELLAR ATAXIA TYPE 21	0.00533598	0.1992427671094542
EPISODIC ATAXIA TYPE 7	0.00533598	0.1992427671094542
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00533598	0.1992427671094542
DERMOTRICHIC SYNDROME	0.005214319	0.19470000752465383
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.005214319	0.19470000752465383
KBG SYNDROME	0.005214319	0.19470000752465383
KABUKI SYNDROME	0.005214319	0.19470000752465383
ANGELMAN SYNDROME	0.005214319	0.19470000752465383
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.19470000752465383
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.19470000752465383
SOTOS SYNDROME	0.005214319	0.19470000752465383
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.005214319	0.19470000752465383
AUTISM	0.005214319	0.19470000752465383
ADAMS-OLIVER SYNDROME	0.005214319	0.19470000752465383
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.005214319	0.19470000752465383
VICI SYNDROME	0.005214319	0.19470000752465383
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.005214319	0.19470000752465383
SCHIZENCEPHALY	0.005214319	0.19470000752465383
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.005214319	0.19470000752465383
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.19470000752465383
MEHMO SYNDROME	0.005214319	0.19470000752465383
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.005214319	0.19470000752465383
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.19470000752465383
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005214319	0.19470000752465383
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.005214319	0.19470000752465383
SMITH-MAGENIS SYNDROME; SMS	0.005214319	0.19470000752465383
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.005214319	0.19470000752465383
GAPO SYNDROME; GAPOS	0.005214319	0.19470000752465383
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005214319	0.19470000752465383
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.005214319	0.19470000752465383
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.19470000752465383
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.005214319	0.19470000752465383
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.005214319	0.19470000752465383
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.005214319	0.19470000752465383
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.19470000752465383
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.19470000752465383
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.005214319	0.19470000752465383
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.19470000752465383
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005214319	0.19470000752465383
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.005214319	0.19470000752465383
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.19470000752465383
EPILEPSY, READING	0.005214319	0.19470000752465383
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.19470000752465383
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.005214319	0.19470000752465383
OCULOCEREBRORENAL SYNDROME OF LOWE	0.005214319	0.19470000752465383
SEVERE CANAVAN DISEASE	0.005214319	0.19470000752465383
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.005214319	0.19470000752465383
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.19470000752465383
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005214319	0.19470000752465383
NEUROCUTANEOUS MELANOCYTOSIS	0.005214319	0.19470000752465383
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.005214319	0.19470000752465383
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.19470000752465383
TEMPLE-BARAITSER SYNDROME	0.005214319	0.19470000752465383
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.005214319	0.19470000752465383
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.005214319	0.19470000752465383
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.005214319	0.19470000752465383
20P13 MICRODELETION SYNDROME	0.005214319	0.19470000752465383
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.005214319	0.19470000752465383
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.005214319	0.19470000752465383
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.19470000752465383
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.005214319	0.19470000752465383
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.19470000752465383
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.005214319	0.19470000752465383
QAZI-MARKOUIZOS SYNDROME	0.005214319	0.19470000752465383
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.19470000752465383
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.19470000752465383
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.19470000752465383
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.19470000752465383
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.005214319	0.19470000752465383
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.19470000752465383
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.005192578999999999	0.19388824703136867
LATHOSTEROLOSIS	0.005192578999999999	0.19388824703136867
GLYCINE ENCEPHALOPATHY; GCE	0.005192578999999999	0.19388824703136867
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.005192578999999999	0.19388824703136867
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.005192578999999999	0.19388824703136867
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.005192578999999999	0.19388824703136867
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.005192578999999999	0.19388824703136867
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.005192578999999999	0.19388824703136867
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.005192578999999999	0.19388824703136867
BENIGN FAMILIAL INFANTILE EPILEPSY	0.005192578999999999	0.19388824703136867
PEHO SYNDROME; PEHO	0.005192578999999999	0.19388824703136867
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.005192578999999999	0.19388824703136867
THYROCEREBRORENAL SYNDROME	0.005192578999999999	0.19388824703136867
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.005192578999999999	0.19388824703136867
NEURAMINIDASE DEFICIENCY	0.005192578999999999	0.19388824703136867
HYPEREKPLEXIA 4; HKPX4	0.005192578999999999	0.19388824703136867
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005192578999999999	0.19388824703136867
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.005192578999999999	0.19388824703136867
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.005192578999999999	0.19388824703136867
INHERITED CREUTZFELDT-JAKOB DISEASE	0.005192578999999999	0.19388824703136867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005192578999999999	0.19388824703136867
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.005192578999999999	0.19388824703136867
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.005192578999999999	0.19388824703136867
JUVENILE HUNTINGTON DISEASE	0.005192578999999999	0.19388824703136867
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.005192578999999999	0.19388824703136867
ATYPICAL JUVENILE PARKINSONISM	0.005192578999999999	0.19388824703136867
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.005192578999999999	0.19388824703136867
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.005192578999999999	0.19388824703136867
NIPAH VIRUS DISEASE	0.005192578999999999	0.19388824703136867
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005126739999999999	0.19142985240775326
USHER SYNDROME	0.005126739999999999	0.19142985240775326
SPINOCEREBELLAR ATAXIA 32; SCA32	0.005126739999999999	0.19142985240775326
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.005126739999999999	0.19142985240775326
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.005126739999999999	0.19142985240775326
JOUBERT SYNDROME 4	0.005126739999999999	0.19142985240775326
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.005126739999999999	0.19142985240775326
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005126739999999999	0.19142985240775326
NON-DISTAL MONOSOMY 10Q	0.005126739999999999	0.19142985240775326
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.005126739999999999	0.19142985240775326
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.005126739999999999	0.19142985240775326
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.005126739999999999	0.19142985240775326
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.005126739999999999	0.19142985240775326
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.18116220235236988
14Q12 MICRODELETION SYNDROME	0.004851759000000001	0.18116220235236988
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004851759000000001	0.18116220235236988
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.18116220235236988
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.004851759000000001	0.18116220235236988
AICARDI-GOUTIÈRES SYNDROME	0.004851759000000001	0.18116220235236988
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004851759000000001	0.18116220235236988
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.18116220235236988
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.004851759000000001	0.18116220235236988
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004851759000000001	0.18116220235236988
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.18116220235236988
ADIPOSIS DOLOROSA	0.004851759000000001	0.18116220235236988
MULTIPLE SULFATASE DEFICIENCY	0.004851759000000001	0.18116220235236988
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.18116220235236988
WITTEVEEN-KOLK SYNDROME	0.004851759000000001	0.18116220235236988
OPTIC PATHWAY GLIOMA	0.004851759000000001	0.18116220235236988
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.004851759000000001	0.18116220235236988
MUCOPOLYSACCHARIDOSIS TYPE 2	0.004851759000000001	0.18116220235236988
AICARDI-GOUTIERES SYNDROME 7	0.004851759000000001	0.18116220235236988
RING CHROMOSOME 22 SYNDROME	0.004851759000000001	0.18116220235236988
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.004851759000000001	0.18116220235236988
MENKES DISEASE	0.004851759000000001	0.18116220235236988
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004851759000000001	0.18116220235236988
ZTTK SYNDROME; ZTTKS	0.004851759000000001	0.18116220235236988
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004851759000000001	0.18116220235236988
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004851759000000001	0.18116220235236988
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.18116220235236988
KLEEFSTRA SYNDROME	0.004851759000000001	0.18116220235236988
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004851759000000001	0.18116220235236988
SNEDDON SYNDROME	0.004851759000000001	0.18116220235236988
DYSOSTEOSCLEROSIS	0.004851759000000001	0.18116220235236988
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.004851759000000001	0.18116220235236988
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.18116220235236988
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004851759000000001	0.18116220235236988
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004851759000000001	0.18116220235236988
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.18116220235236988
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004851759000000001	0.18116220235236988
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.004851759000000001	0.18116220235236988
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004851759000000001	0.18116220235236988
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004851759000000001	0.18116220235236988
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.17448369866936694
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.0046729	0.17448369866936694
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.17448369866936694
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.17448369866936694
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0046729	0.17448369866936694
SCHIZOPHRENIA	0.0046729	0.17448369866936694
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.17448369866936694
ISAAC SYNDROME	0.0046729	0.17448369866936694
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.0046729	0.17448369866936694
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.17448369866936694
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.0046729	0.17448369866936694
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.17448369866936694
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.17448369866936694
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0046729	0.17448369866936694
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.0046729	0.17448369866936694
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.0046729	0.17448369866936694
CINCA SYNDROME	0.0046729	0.17448369866936694
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.17448369866936694
SACCHAROPINURIA	0.0046729	0.17448369866936694
6Q16 MICRODELETION SYNDROME	0.0046729	0.17448369866936694
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0046729	0.17448369866936694
DYSTONIA 3, TORSION, X-LINKED	0.00465116	0.1736719381760818
CREUTZFELDT-JAKOB DISEASE; CJD	0.00465116	0.1736719381760818
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.00465116	0.1736719381760818
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00465116	0.1736719381760818
HYPEREKPLEXIA 2; HKPX2	0.00465116	0.1736719381760818
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.00465116	0.1736719381760818
CARIBBEAN PARKINSONISM	0.00465116	0.1736719381760818
SPINOCEREBELLAR ATAXIA TYPE 37	0.00465116	0.1736719381760818
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.00465116	0.1736719381760818
NYSTAGMUS, MYOCLONIC	0.00465116	0.1736719381760818
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00465116	0.1736719381760818
9P13 MICRODELETION SYNDROME	0.00465116	0.1736719381760818
ABETA AMYLOIDOSIS, IOWA TYPE	0.00465116	0.1736719381760818
DYSTONIA 11, MYOCLONIC	0.00465116	0.1736719381760818
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.00465116	0.1736719381760818
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00465116	0.1736719381760818
OROFACIODIGITAL SYNDROME III	0.00465116	0.1736719381760818
DYSTONIA 15, MYOCLONIC; DYT15	0.00465116	0.1736719381760818
DYSTONIA 23; DYT23	0.00465116	0.1736719381760818
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00465116	0.1736719381760818
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00465116	0.1736719381760818
X-LINKED DYSTONIA-PARKINSONISM	0.00465116	0.1736719381760818
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00465116	0.1736719381760818
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.160945893497083
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.160945893497083
DYSOSTEOSCLEROSIS	0.00431034	0.160945893497083
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00431034	0.160945893497083
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.160945893497083
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00431034	0.160945893497083
AICARDI-GOUTIERES SYNDROME 6	0.00431034	0.160945893497083
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00431034	0.160945893497083
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.160945893497083
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.160945893497083
TRISOMY 5P	0.00431034	0.160945893497083
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.160945893497083
PANDAS	0.00431034	0.160945893497083
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00431034	0.160945893497083
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.160945893497083
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00431034	0.160945893497083
DOWN SYNDROME	0.00431034	0.160945893497083
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.160945893497083
HAMAMY SYNDROME; HMMS	0.00431034	0.160945893497083
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.160945893497083
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.160945893497083
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00431034	0.160945893497083
MULTIPLE CARBOXYLASE DEFICIENCY	0.0041910590000000005	0.15649200189636808
DISTAL MONOSOMY 3P	0.0041910590000000005	0.15649200189636808
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0041910590000000005	0.15649200189636808
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.0041910590000000005	0.15649200189636808
MPDU1-CDG	0.0041910590000000005	0.15649200189636808
PAPILLOMA OF CHOROID PLEXUS	0.0041910590000000005	0.15649200189636808
ALG2-CDG	0.0041910590000000005	0.15649200189636808
CRISPONI SYNDROME	0.0041910590000000005	0.15649200189636808
ALG9-CDG	0.0041910590000000005	0.15649200189636808
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.0041910590000000005	0.15649200189636808
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0041910590000000005	0.15649200189636808
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.0041910590000000005	0.15649200189636808
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0041910590000000005	0.15649200189636808
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.0041910590000000005	0.15649200189636808
HYPERLYSINEMIA, TYPE I	0.0041910590000000005	0.15649200189636808
BENIGN FAMILIAL NEONATAL EPILEPSY	0.0041910590000000005	0.15649200189636808
HOLOPROSENCEPHALY	0.0041910590000000005	0.15649200189636808
TRISOMY X	0.0041910590000000005	0.15649200189636808
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0041910590000000005	0.15649200189636808
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0041910590000000005	0.15649200189636808
THANATOPHORIC DYSPLASIA TYPE 2	0.0041910590000000005	0.15649200189636808
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.0041910590000000005	0.15649200189636808
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.0041910590000000005	0.15649200189636808
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.0041910590000000005	0.15649200189636808
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0041910590000000005	0.15649200189636808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.0041910590000000005	0.15649200189636808
FOIX-CHAVANY-MARIE SYNDROME	0.0041910590000000005	0.15649200189636808
CONGENITAL TOXOPLASMOSIS	0.0041910590000000005	0.15649200189636808
ONDINE SYNDROME	0.0041910590000000005	0.15649200189636808
ENDOCARDIAL FIBROELASTOSIS	0.0041910590000000005	0.15649200189636808
LYMPHANGIOLEIOMYOMATOSIS	0.0041910590000000005	0.15649200189636808
NOONAN SYNDROME 7; NS7	0.0041910590000000005	0.15649200189636808
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0041910590000000005	0.15649200189636808
INCONTINENTIA PIGMENTI	0.0041910590000000005	0.15649200189636808
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0041910590000000005	0.15649200189636808
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0041910590000000005	0.15649200189636808
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0041910590000000005	0.15649200189636808
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.0041910590000000005	0.15649200189636808
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.003704859	0.13833754229033193
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.003704859	0.13833754229033193
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.003704859	0.13833754229033193
SALLA DISEASE	0.003704859	0.13833754229033193
CAMOS SYNDROME	0.003704859	0.13833754229033193
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.003704859	0.13833754229033193
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003704859	0.13833754229033193
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.003704859	0.13833754229033193
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.003704859	0.13833754229033193
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.003704859	0.13833754229033193
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.003704859	0.13833754229033193
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.003704859	0.13833754229033193
LISSENCEPHALY, X-LINKED, 1; LISX1	0.003704859	0.13833754229033193
GLUTATHIONE SYNTHETASE DEFICIENCY	0.003704859	0.13833754229033193
CEREBELLOPARENCHYMAL DISORDER II	0.003704859	0.13833754229033193
PYRUVATE DEHYDROGENASE DEFICIENCY	0.0037048589999999996	0.13833754229033193
NIEMANN-PICK DISEASE, TYPE C2	0.0037048589999999996	0.13833754229033193
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.0037048589999999996	0.13833754229033193
CHROMOSOME 1P35 DELETION SYNDROME	0.0037048589999999996	0.13833754229033193
FREE SIALIC ACID STORAGE DISEASE	0.0037048589999999996	0.13833754229033193
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0037048589999999996	0.13833754229033193
PELIZAEUS-MERZBACHER DISEASE	0.0037048589999999996	0.13833754229033193
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0037048589999999996	0.13833754229033193
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0037048589999999996	0.13833754229033193
48,XXYY SYNDROME	0.0037048589999999996	0.13833754229033193
COCKAYNE SYNDROME A; CSA	0.0037048589999999996	0.13833754229033193
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.0037048589999999996	0.13833754229033193
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.0037048589999999996	0.13833754229033193
METACHROMATIC LEUKODYSTROPHY	0.0037048589999999996	0.13833754229033193
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0037048589999999996	0.13833754229033193
OCULODENTODIGITAL DYSPLASIA	0.0037048589999999996	0.13833754229033193
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0037048589999999996	0.13833754229033193
KALLMANN SYNDROME	0.0037048589999999996	0.13833754229033193
LEIGH SYNDROME; LS	0.0037048589999999996	0.13833754229033193
PGM3-CDG	0.0037048589999999996	0.13833754229033193
VASCULAR EHLERS-DANLOS SYNDROME	0.00364964	0.1362756930410812
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00364964	0.1362756930410812
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00364964	0.1362756930410812
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00364964	0.1362756930410812
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00364964	0.1362756930410812
MONOAMINE OXIDASE A DEFICIENCY	0.00364964	0.1362756930410812
FLOATING-HARBOR SYNDROME	0.00364964	0.1362756930410812
MONILETHRIX	0.00364964	0.1362756930410812
CLASSICAL EHLERS-DANLOS SYNDROME	0.00364964	0.1362756930410812
ALPHA-THALASSEMIA	0.00364964	0.1362756930410812
MUCOLIPIDOSIS TYPE III	0.00364964	0.1362756930410812
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00364964	0.1362756930410812
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00364964	0.1362756930410812
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00364964	0.1362756930410812
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00364964	0.1362756930410812
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00364964	0.1362756930410812
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.00364964	0.1362756930410812
RING CHROMOSOME 1 SYNDROME	0.00364964	0.1362756930410812
EARLY-ONSET SCHIZOPHRENIA	0.00364964	0.1362756930410812
MEDULLOBLASTOMA	0.00364964	0.1362756930410812
KERATODERMA HEREDITARIUM MUTILANS	0.00364964	0.1362756930410812
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00364964	0.1362756930410812
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00364964	0.1362756930410812
FETAL ALCOHOL SYNDROME	0.00364964	0.1362756930410812
CONGENITAL SHORT BOWEL SYNDROME	0.00364964	0.1362756930410812
SECKEL SYNDROME 4	0.00364964	0.1362756930410812
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00364964	0.1362756930410812
HIDROTIC ECTODERMAL DYSPLASIA	0.00364964	0.1362756930410812
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.00364964	0.1362756930410812
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00364964	0.1362756930410812
BARDET-BIEDL SYNDROME 18; BBS18	0.00364964	0.1362756930410812
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00364964	0.1362756930410812
ISOLATED ECTOPIA LENTIS	0.00364964	0.1362756930410812
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00364964	0.1362756930410812
TRISOMY 18	0.00364964	0.1362756930410812
FOCAL DERMAL HYPOPLASIA	0.00364964	0.1362756930410812
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00364964	0.1362756930410812
SCHIZOPHRENIA 19; SCZD19	0.00364964	0.1362756930410812
TETRASOMY X	0.00364964	0.1362756930410812
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00364964	0.1362756930410812
LEPRECHAUNISM	0.00364964	0.1362756930410812
DEAFNESS-HYPOGONADISM SYNDROME	0.00364964	0.1362756930410812
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00364964	0.1362756930410812
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00364964	0.1362756930410812
VOGT-KOYANAGI-HARADA DISEASE	0.00364964	0.1362756930410812
REACTIVE ARTHRITIS	0.00364964	0.1362756930410812
JOUBERT SYNDROME 31; JBTS31	0.00364964	0.1362756930410812
BARDET-BIEDL SYNDROME 5; BBS5	0.00364964	0.1362756930410812
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00364964	0.1362756930410812
BARDET-BIEDL SYNDROME 8; BBS8	0.00364964	0.1362756930410812
BARDET-BIEDL SYNDROME 10; BBS10	0.00364964	0.1362756930410812
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00364964	0.1362756930410812
BARDET-BIEDL SYNDROME 12; BBS12	0.00364964	0.1362756930410812
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00364964	0.1362756930410812
DK1-CDG	0.00364964	0.1362756930410812
BARDET-BIEDL SYNDROME 16; BBS16	0.00364964	0.1362756930410812
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00364964	0.1362756930410812
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00364964	0.1362756930410812
BARDET-BIEDL SYNDROME 17; BBS17	0.00364964	0.1362756930410812
RIN2 SYNDROME	0.00364964	0.1362756930410812
PACHYONYCHIA CONGENITA	0.00364964	0.1362756930410812
ISOTRETINOIN SYNDROME	0.00364964	0.1362756930410812
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00364964	0.1362756930410812
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00364964	0.1362756930410812
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00364964	0.1362756930410812
RHIZOMELIC SYNDROME, URBACH TYPE	0.00364964	0.1362756930410812
TRISOMY 4P	0.00364964	0.1362756930410812
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00364964	0.1362756930410812
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00364964	0.1362756930410812
LAMELLAR ICHTHYOSIS	0.00364964	0.1362756930410812
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00364964	0.1362756930410812
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00364964	0.1362756930410812
DUCHENNE MUSCULAR DYSTROPHY	0.00364964	0.1362756930410812
SPINOCEREBELLAR ATAXIA TYPE 32	0.00364964	0.1362756930410812
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00364964	0.1362756930410812
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00364964	0.1362756930410812
SCLEROSTEOSIS 1; SOST1	0.00364964	0.1362756930410812
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00364964	0.1362756930410812
AARSKOG-SCOTT SYNDROME	0.00364964	0.1362756930410812
LYSINURIC PROTEIN INTOLERANCE	0.00364964	0.1362756930410812
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00364964	0.1362756930410812
NON-DISTAL TRISOMY 10Q	0.00364964	0.1362756930410812
NON-DISTAL TRISOMY 13Q	0.00364964	0.1362756930410812
DISTAL TRISOMY 14Q	0.00364964	0.1362756930410812
TRICHOHEPATOENTERIC SYNDROME 1	0.00364964	0.1362756930410812
PYCNODYSOSTOSIS	0.00364964	0.1362756930410812
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00364964	0.1362756930410812
DISTAL TRISOMY 18Q	0.00364964	0.1362756930410812
DISTAL MONOSOMY 13Q	0.00364964	0.1362756930410812
PRUNE BELLY SYNDROME	0.00364964	0.1362756930410812
SECKEL SYNDROME	0.00364964	0.1362756930410812
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.00364964	0.1362756930410812
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00364964	0.1362756930410812
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00364964	0.1362756930410812
COWCHOCK SYNDROME; COWCK	0.00364964	0.1362756930410812
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00364964	0.1362756930410812
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.1362756930410812
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00364964	0.1362756930410812
ISOLATED CLOVERLEAF SKULL SYNDROME	0.00364964	0.1362756930410812
MALARIA	0.00364964	0.1362756930410812
ISOLATED KLIPPEL-FEIL SYNDROME	0.00364964	0.1362756930410812
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00364964	0.1362756930410812
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00364964	0.1362756930410812
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00364964	0.1362756930410812
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00364964	0.1362756930410812
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00364964	0.1362756930410812
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00364964	0.1362756930410812
ALG12-CDG	0.00364964	0.1362756930410812
KEIPERT SYNDROME	0.00364964	0.1362756930410812
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00316344	0.11812123343504508
FAMILIAL PAROXYSMAL ATAXIA	0.00316344	0.11812123343504508
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00316344	0.11812123343504508
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.00316344	0.11812123343504508
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00316344	0.11812123343504508
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00316344	0.11812123343504508
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00316344	0.11812123343504508
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00316344	0.11812123343504508
JOUBERT SYNDROME 32; JBTS32	0.00316344	0.11812123343504508
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00316344	0.11812123343504508
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.00316344	0.11812123343504508
SPASTIC PARAPLEGIA TYPE 2	0.00316344	0.11812123343504508
ALLAN-HERNDON-DUDLEY SYNDROME	0.00316344	0.11812123343504508
MACHADO-JOSEPH DISEASE; MJD	0.00316344	0.11812123343504508
ACERULOPLASMINEMIA	0.00316344	0.11812123343504508
SANDHOFF DISEASE	0.00316344	0.11812123343504508
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00316344	0.11812123343504508
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00316344	0.11812123343504508
SPINOCEREBELLAR ATAXIA TYPE 4	0.00316344	0.11812123343504508
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00316344	0.11812123343504508
PELLAGRA-LIKE SYNDROME	0.00316344	0.11812123343504508
SPINOCEREBELLAR ATAXIA 31	0.00316344	0.11812123343504508
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00316344	0.11812123343504508
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00316344	0.11812123343504508
ACERULOPLASMINEMIA	0.00316344	0.11812123343504508
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00316344	0.11812123343504508
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00316344	0.11812123343504508
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00316344	0.11812123343504508
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00316344	0.11812123343504508
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00316344	0.11812123343504508
PEROXISOME BIOGENESIS DISORDER 6B	0.00316344	0.11812123343504508
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00316344	0.11812123343504508
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00316344	0.11812123343504508
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00316344	0.11812123343504508
ERDHEIM-CHESTER DISEASE	0.00316344	0.11812123343504508
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00316344	0.11812123343504508
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00316344	0.11812123343504508
MARINESCO-SJOGREN SYNDROME; MSS	0.00316344	0.11812123343504508
EPISODIC ATAXIA, TYPE 8	0.00316344	0.11812123343504508
CLASSIC GALACTOSEMIA	0.00316344	0.11812123343504508
AGEL AMYLOIDOSIS	0.00316344	0.11812123343504508
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00316344	0.11812123343504508
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00316344	0.11812123343504508
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316344	0.11812123343504508
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.00316344	0.11812123343504508
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00316344	0.11812123343504508
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00316344	0.11812123343504508
MARINESCO-SJÖGREN SYNDROME	0.00316344	0.11812123343504508
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00316344	0.11812123343504508
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00316344	0.11812123343504508
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00316344	0.11812123343504508
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00316344	0.11812123343504508
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00316344	0.11812123343504508
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.00316344	0.11812123343504508
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00316344	0.11812123343504508
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00316344	0.11812123343504508
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.002227759	0.08318338292365988
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.002227759	0.08318338292365988
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.002227759	0.08318338292365988
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002227759	0.08318338292365988
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.002227759	0.08318338292365988
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.002227759	0.08318338292365988
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.002227759	0.08318338292365988
SJÖGREN-LARSSON SYNDROME	0.002227759	0.08318338292365988
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.002227759	0.08318338292365988
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002227759	0.08318338292365988
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.002227759	0.08318338292365988
FAMILIAL THROMBOCYTOSIS	0.002227759	0.08318338292365988
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002227759	0.08318338292365988
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002227759	0.08318338292365988
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002227759	0.08318338292365988
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.002227759	0.08318338292365988
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.002227759	0.08318338292365988
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.002227759	0.08318338292365988
RAPID-ONSET DYSTONIA-PARKINSONISM	0.002227759	0.08318338292365988
OCULOCEREBROCUTANEOUS SYNDROME	0.002227759	0.08318338292365988
WEAVER SYNDROME	0.002227759	0.08318338292365988
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.002227759	0.08318338292365988
EPISODIC ATAXIA, TYPE 6	0.002227759	0.08318338292365988
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.002227759	0.08318338292365988
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.002227759	0.08318338292365988
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002227759	0.08318338292365988
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.002227759	0.08318338292365988
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002227759	0.08318338292365988
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.002227759	0.08318338292365988
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.002227759	0.08318338292365988
WYBURN-MASON SYNDROME	0.002227759	0.08318338292365988
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.002227759	0.08318338292365988
SNEDDON SYNDROME	0.002227759	0.08318338292365988
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.002227759	0.08318338292365988
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.002227759	0.08318338292365988
MYASTHENIA GRAVIS	0.002227759	0.08318338292365988
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.002227759	0.08318338292365988
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.002227759	0.08318338292365988
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.002227759	0.08318338292365988
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002227759	0.08318338292365988
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002227759	0.08318338292365988
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002227759	0.08318338292365988
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.002227759	0.08318338292365988
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.002227759	0.08318338292365988
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07537046822195893
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002018519	0.07537046822195893
BETA-KETOTHIOLASE DEFICIENCY	0.002018519	0.07537046822195893
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.07537046822195893
MEVALONIC ACIDURIA	0.002018519	0.07537046822195893
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.002018519	0.07537046822195893
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002018519	0.07537046822195893
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.002018519	0.07537046822195893
2Q23.1 MICRODELETION SYNDROME	0.002018519	0.07537046822195893
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002018519	0.07537046822195893
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002018519	0.07537046822195893
SIALIDOSIS TYPE 2	0.002018519	0.07537046822195893
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07537046822195893
CITRULLINEMIA TYPE I	0.002018519	0.07537046822195893
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.002018519	0.07537046822195893
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.002018519	0.07537046822195893
INFANTILE REFSUM DISEASE	0.002018519	0.07537046822195893
EPISODIC ATAXIA TYPE 6	0.002018519	0.07537046822195893
RFT1-CDG	0.002018519	0.07537046822195893
OROFACIODIGITAL SYNDROME TYPE 1	0.002018519	0.07537046822195893
JOUBERT SYNDROME	0.002018519	0.07537046822195893
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.07537046822195893
OROFACIODIGITAL SYNDROME TYPE 6	0.002018519	0.07537046822195893
GM1 GANGLIOSIDOSIS	0.002018519	0.07537046822195893
15Q11Q13 MICRODUPLICATION SYNDROME	0.002018519	0.07537046822195893
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002018519	0.07537046822195893
EAST SYNDROME	0.002018519	0.07537046822195893
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.002018519	0.07537046822195893
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002018519	0.07537046822195893
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002018519	0.07537046822195893
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.002018519	0.07537046822195893
MAPLE SYRUP URINE DISEASE	0.002018519	0.07537046822195893
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.07537046822195893
CEDNIK SYNDROME	0.002018519	0.07537046822195893
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002018519	0.07537046822195893
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.002018519	0.07537046822195893
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07537046822195893
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002018519	0.07537046822195893
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.002018519	0.07537046822195893
SRD5A3-CDG	0.002018519	0.07537046822195893
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002018519	0.07537046822195893
DYSEQUILIBRIUM SYNDROME	0.002018519	0.07537046822195893
FAMILIAL DYSAUTONOMIA	0.002018519	0.07537046822195893
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07537046822195893
JOUBERT SYNDROME WITH RENAL DEFECT	0.002018519	0.07537046822195893
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.002018519	0.07537046822195893
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07537046822195893
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002018519	0.07537046822195893
PMM2-CDG	0.002018519	0.07537046822195893
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07537046822195893
ALG11-CDG	0.002018519	0.07537046822195893
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07537046822195893
GRISCELLI SYNDROME	0.002018519	0.07537046822195893
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002018519	0.07537046822195893
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07537046822195893
COACH SYNDROME	0.002018519	0.07537046822195893
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002018519	0.07537046822195893
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002018519	0.07537046822195893
MYHRE SYNDROME	0.002018519	0.07537046822195893
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.002018519	0.07537046822195893
FLYNN-AIRD SYNDROME	0.002018519	0.07537046822195893
ARGININOSUCCINIC ACIDURIA	0.002018519	0.07537046822195893
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07537046822195893
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002018519	0.07537046822195893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002018519	0.07537046822195893
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002018519	0.07537046822195893
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.002018519	0.07537046822195893
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.002018519	0.07537046822195893
FOLATE MALABSORPTION, HEREDITARY	0.002018519	0.07537046822195893
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.002018519	0.07537046822195893
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.002018519	0.07537046822195893
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.002018519	0.07537046822195893
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002018519	0.07537046822195893
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.002018519	0.07537046822195893
ELEJALDE DISEASE	0.002018519	0.07537046822195893
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.07537046822195893
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07537046822195893
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.002018519	0.07537046822195893
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.002018519	0.07537046822195893
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.002018519	0.07537046822195893
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002018519	0.07537046822195893
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002018519	0.07537046822195893
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002018519	0.07537046822195893
SULFOCYSTEINURIA	0.002018519	0.07537046822195893
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002018519	0.07537046822195893
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.002018519	0.07537046822195893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002018519	0.07537046822195893
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.002018519	0.07537046822195893
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07537046822195893
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002018519	0.07537046822195893
MAPLE SYRUP URINE DISEASE; MSUD	0.002018519	0.07537046822195893
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.002018519	0.07537046822195893
MEGALENCEPHALY WITH DYSMYELINATION	0.002018519	0.07537046822195893
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.002018519	0.07537046822195893
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002018519	0.07537046822195893
LISSENCEPHALY 3; LIS3	0.002018519	0.07537046822195893
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07537046822195893
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.002018519	0.07537046822195893
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002018519	0.07537046822195893
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07537046822195893
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002018519	0.07537046822195893
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002018519	0.07537046822195893
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.002018519	0.07537046822195893
CITRULLINEMIA, CLASSIC	0.002018519	0.07537046822195893
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002018519	0.07537046822195893
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07537046822195893
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002018519	0.07537046822195893
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002018519	0.07537046822195893
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07537046822195893
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002018519	0.07537046822195893
GITELMAN SYNDROME	0.002018519	0.07537046822195893
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.002018519	0.07537046822195893
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.002018519	0.07537046822195893
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002018519	0.07537046822195893
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.002018519	0.07537046822195893
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002018519	0.07537046822195893
DIAMINOPENTANURIA	0.002018519	0.07537046822195893
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002018519	0.07537046822195893
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002018519	0.07537046822195893
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00168634	0.06296707406837301
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00168634	0.06296707406837301
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00168634	0.06296707406837301
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00168634	0.06296707406837301
SYRINGOMYELIA, ISOLATED	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 34	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.00168634	0.06296707406837301
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00168634	0.06296707406837301
POSTPOLIOMYELITIS SYNDROME	0.00168634	0.06296707406837301
TREMOR, HEREDITARY ESSENTIAL, 1	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.00168634	0.06296707406837301
LESCH-NYHAN SYNDROME; LNS	0.00168634	0.06296707406837301
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00168634	0.06296707406837301
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 31	0.00168634	0.06296707406837301
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837301
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00168634	0.06296707406837301
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837301
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 20	0.00168634	0.06296707406837301
HUNTINGTON DISEASE-LIKE 1	0.00168634	0.06296707406837301
EPISODIC ATAXIA TYPE 5	0.00168634	0.06296707406837301
WILSON DISEASE	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 30	0.00168634	0.06296707406837301
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00168634	0.06296707406837301
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.00168634	0.06296707406837301
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00168634	0.06296707406837301
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00168634	0.06296707406837301
DYSTONIA 16	0.00168634	0.06296707406837301
UROCANIC ACIDURIA	0.00168634	0.06296707406837301
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00168634	0.06296707406837301
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00168634	0.06296707406837301
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00168634	0.06296707406837301
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00168634	0.06296707406837301
PARKINSON DISEASE, LATE-ONSET; PD	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00168634	0.06296707406837301
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00168634	0.06296707406837301
PERRY SYNDROME	0.00168634	0.06296707406837301
ACHONDROPLASIA	0.00168634	0.06296707406837301
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00168634	0.06296707406837301
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.00168634	0.06296707406837301
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.06296707406837301
NOONAN SYNDROME	0.00168634	0.06296707406837301
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.00168634	0.06296707406837301
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00168634	0.06296707406837301
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00168634	0.06296707406837301
HUNTINGTON DISEASE-LIKE 2	0.00168634	0.06296707406837301
WOUND BOTULISM	0.00168634	0.06296707406837301
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00168634	0.06296707406837301
INFANT BOTULISM	0.00168634	0.06296707406837301
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00168634	0.06296707406837301
INTESTINAL BOTULISM	0.00168634	0.06296707406837301
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 42	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 15	0.00168634	0.06296707406837301
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00168634	0.06296707406837301
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00168634	0.06296707406837301
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00168634	0.06296707406837301
FOODBORNE BOTULISM	0.00168634	0.06296707406837301
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00168634	0.06296707406837301
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00168634	0.06296707406837301
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00168634	0.06296707406837301
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00168634	0.06296707406837301
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.00168634	0.06296707406837301
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00168634	0.06296707406837301
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00168634	0.06296707406837301
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00168634	0.06296707406837301
WILSON DISEASE	0.00168634	0.06296707406837301
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 12	0.00168634	0.06296707406837301
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00168634	0.06296707406837301
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00168634	0.06296707406837301
SYDENHAM CHOREA	0.00168634	0.06296707406837301
NATIVE AMERICAN MYOPATHY	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00168634	0.06296707406837301
PEROXISOME BIOGENESIS DISORDER 5B	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00168634	0.06296707406837301
UNVERRICHT-LUNDBORG DISEASE	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 13	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 40	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 14	0.00168634	0.06296707406837301
OPTIC ATROPHY 2	0.00168634	0.06296707406837301
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00168634	0.06296707406837301
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 38	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 26	0.00168634	0.06296707406837301
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.00168634	0.06296707406837301
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00168634	0.06296707406837301
EPISODIC ATAXIA, TYPE 5	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00168634	0.06296707406837301
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 23	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 28	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 20	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 26	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00168634	0.06296707406837301
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.00168634	0.06296707406837301
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00168634	0.06296707406837301
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00168634	0.06296707406837301
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00168634	0.06296707406837301
TURNPENNY-FRY SYNDROME; TPFS	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00168634	0.06296707406837301
MULTIPLE SYSTEM ATROPHY	0.00168634	0.06296707406837301
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00168634	0.06296707406837301
KENNEDY DISEASE	0.00168634	0.06296707406837301
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA-PRECOCIOUS PUBERTY SYNDROME	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00168634	0.06296707406837301
EPISODIC ATAXIA, TYPE 7; EA7	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 6	0.00168634	0.06296707406837301
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00168634	0.06296707406837301
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00168634	0.06296707406837301
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.00168634	0.06296707406837301
PRIMARY DYSTONIA, DYT6 TYPE	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 2	0.00168634	0.06296707406837301
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 1	0.00168634	0.06296707406837301
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00168634	0.06296707406837301
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 27	0.00168634	0.06296707406837301
MYASTHENIA GRAVIS; MG	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00168634	0.06296707406837301
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00168634	0.06296707406837301
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00168634	0.06296707406837301
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00168634	0.06296707406837301
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00168634	0.06296707406837301
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00168634	0.06296707406837301
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00168634	0.06296707406837301
DYSTONIA 12; DYT12	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 11	0.00168634	0.06296707406837301
PRIMARY DYSTONIA, DYT17 TYPE	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 18	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00168634	0.06296707406837301
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00168634	0.06296707406837301
EPISODIC ATAXIA TYPE 1	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00168634	0.06296707406837301
CHIARI MALFORMATION TYPE I	0.00168634	0.06296707406837301
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.00168634	0.06296707406837301
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00168634	0.06296707406837301
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00168634	0.06296707406837301
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 36	0.00168634	0.06296707406837301
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.00168634	0.06296707406837301
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00168634	0.06296707406837301
LEBER OPTIC ATROPHY AND DYSTONIA	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.00168634	0.06296707406837301
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00168634	0.06296707406837301
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00168634	0.06296707406837301
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00168634	0.06296707406837301
MOEBIUS SYNDROME; MBS	0.00168634	0.06296707406837301
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00168634	0.06296707406837301
EPISODIC ATAXIA, TYPE 1; EA1	0.00168634	0.06296707406837301
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00168634	0.06296707406837301
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00168634	0.06296707406837301
MACHADO-JOSEPH DISEASE TYPE 1	0.00168634	0.06296707406837301
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00168634	0.06296707406837301
MACHADO-JOSEPH DISEASE TYPE 2	0.00168634	0.06296707406837301
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00168634	0.06296707406837301
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00168634	0.06296707406837301
MACHADO-JOSEPH DISEASE TYPE 3	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 43	0.00168634	0.06296707406837301
PURE MITOCHONDRIAL MYOPATHY	0.00168634	0.06296707406837301
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00168634	0.06296707406837301
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00168634	0.06296707406837301
JUVENILE DERMATOMYOSITIS	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 3	0.00168634	0.06296707406837301
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA TYPE 7	0.00168634	0.06296707406837301
MAST SYNDROME	0.00168634	0.06296707406837301
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00168634	0.06296707406837301
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.00168634	0.06296707406837301
CEREBELLAR ATAXIA, CAYMAN TYPE	0.00168634	0.06296707406837301
MYOPATHY AND DIABETES MELLITUS	0.00168634	0.06296707406837301
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00168634	0.06296707406837301
DISTAL MYOTILINOPATHY	0.00168634	0.06296707406837301
BOTULISM	0.00168634	0.06296707406837301
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00168634	0.06296707406837301
POSTORGASMIC ILLNESS SYNDROME	0.00168634	0.06296707406837301
SPASTIC PARAPLEGIA TYPE 7	0.00168634	0.06296707406837301
FRIEDREICH ATAXIA	0.00168634	0.06296707406837301
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.06296707406837301
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00168634	0.06296707406837301
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00168634	0.06296707406837301
OROMANDIBULAR DYSTONIA	0.00168634	0.06296707406837301
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.00168634	0.06296707406837301
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00168634	0.06296707406837301
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00168634	0.06296707406837301
PRIMARY DYSTONIA, DYT2 TYPE	0.00168634	0.06296707406837301
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00168634	0.06296707406837301
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00168634	0.06296707406837301
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00168634	0.06296707406837301
EPISODIC ATAXIA, TYPE 2	0.00168634	0.06296707406837301
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 21	0.0014770999999999999	0.05515415936667206
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0014770999999999999	0.05515415936667206
NAVAJO NEUROHEPATOPATHY	0.0014770999999999999	0.05515415936667206
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05515415936667206
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.0014770999999999999	0.05515415936667206
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05515415936667206
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05515415936667206
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05515415936667206
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05515415936667206
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05515415936667206
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.05515415936667206
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05515415936667206
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05515415936667206
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0014770999999999999	0.05515415936667206
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05515415936667206
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05515415936667206
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 17; JBTS17	0.0014770999999999999	0.05515415936667206
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05515415936667206
CHANARIN-DORFMAN SYNDROME	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05515415936667206
LEGIONELLOSIS	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0014770999999999999	0.05515415936667206
PIEBALDISM	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 6	0.0014770999999999999	0.05515415936667206
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0014770999999999999	0.05515415936667206
RHOMBENCEPHALOSYNAPSIS	0.0014770999999999999	0.05515415936667206
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05515415936667206
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 14	0.0014770999999999999	0.05515415936667206
ARIMA SYNDROME	0.0014770999999999999	0.05515415936667206
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05515415936667206
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05515415936667206
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05515415936667206
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 15	0.0014770999999999999	0.05515415936667206
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 7	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05515415936667206
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05515415936667206
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05515415936667206
REFSUM DISEASE	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 8	0.0014770999999999999	0.05515415936667206
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05515415936667206
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0014770999999999999	0.05515415936667206
USHER SYNDROME TYPE 1	0.0014770999999999999	0.05515415936667206
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05515415936667206
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05515415936667206
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0014770999999999999	0.05515415936667206
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05515415936667206
KIKUCHI-FUJIMOTO DISEASE	0.0014770999999999999	0.05515415936667206
REVESZ SYNDROME	0.0014770999999999999	0.05515415936667206
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05515415936667206
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05515415936667206
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05515415936667206
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 5	0.0014770999999999999	0.05515415936667206
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05515415936667206
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0014770999999999999	0.05515415936667206
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05515415936667206
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05515415936667206
PITUITARY CARCINOMA	0.0014770999999999999	0.05515415936667206
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05515415936667206
WAARDENBURG-SHAH SYNDROME	0.0014770999999999999	0.05515415936667206
46,XX GONADAL DYSGENESIS	0.0014770999999999999	0.05515415936667206
RICHARDS-RUNDLE SYNDROME; RRNS	0.0014770999999999999	0.05515415936667206
LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05515415936667206
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0014770999999999999	0.05515415936667206
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05515415936667206
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.0014770999999999999	0.05515415936667206
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05515415936667206
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0014770999999999999	0.05515415936667206
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05515415936667206
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0014770999999999999	0.05515415936667206
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0014770999999999999	0.05515415936667206
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05515415936667206
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05515415936667206
CLASSIC HODGKIN LYMPHOMA	0.0014770999999999999	0.05515415936667206
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0014770999999999999	0.05515415936667206
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05515415936667206
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05515415936667206
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 33; JBTS33	0.0014770999999999999	0.05515415936667206
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 25	0.0014770999999999999	0.05515415936667206
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05515415936667206
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05515415936667206
RIDDLE SYNDROME	0.0014770999999999999	0.05515415936667206
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05515415936667206
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05515415936667206
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0014770999999999999	0.05515415936667206
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05515415936667206
CHIARI MALFORMATION TYPE II	0.0014770999999999999	0.05515415936667206
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05515415936667206
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05515415936667206
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05515415936667206
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0014770999999999999	0.05515415936667206
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05515415936667206
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05515415936667206
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05515415936667206
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05515415936667206
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05515415936667206
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05515415936667206
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05515415936667206
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05515415936667206
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05515415936667206
CHAND SYNDROME	0.0014770999999999999	0.05515415936667206
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0014770999999999999	0.05515415936667206
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05515415936667206
GIANT CELL ARTERITIS	0.0014770999999999999	0.05515415936667206
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05515415936667206
WALDENSTRÖM MACROGLOBULINEMIA	0.0014770999999999999	0.05515415936667206
HOYERAAL-HREIDARSSON SYNDROME	0.0014770999999999999	0.05515415936667206
MECKEL SYNDROME 13; MKS13	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 28	0.0014770999999999999	0.05515415936667206
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 27	0.0014770999999999999	0.05515415936667206
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0014770999999999999	0.05515415936667206
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05515415936667206
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05515415936667206
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0014770999999999999	0.05515415936667206
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05515415936667206
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05515415936667206
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05515415936667206
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05515415936667206
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05515415936667206
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05515415936667206
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0014770999999999999	0.05515415936667206
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05515415936667206
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05515415936667206
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05515415936667206
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05515415936667206
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05515415936667206
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05515415936667206
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05515415936667206
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05515415936667206
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0014770999999999999	0.05515415936667206
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 1	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 2	0.0014770999999999999	0.05515415936667206
SENIOR-LOKEN SYNDROME	0.0014770999999999999	0.05515415936667206
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.05515415936667206
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 35; JBTS35	0.0014770999999999999	0.05515415936667206
GEMIGNANI SYNDROME	0.0014770999999999999	0.05515415936667206
CEREBROFACIOARTICULAR SYNDROME	0.0014770999999999999	0.05515415936667206
TYPHOID	0.0014770999999999999	0.05515415936667206
TURCOT SYNDROME WITH POLYPOSIS	0.0014770999999999999	0.05515415936667206
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0014770999999999999	0.05515415936667206
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0014770999999999999	0.05515415936667206
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0014770999999999999	0.05515415936667206
RAVINE SYNDROME	0.0014770999999999999	0.05515415936667206
BOUCHER-NEUHAUSER SYNDROME	0.0014770999999999999	0.05515415936667206
JOUBERT SYNDROME 3; JBTS3	0.0014770999999999999	0.05515415936667206
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05515415936667206
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05515415936667206
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0014770999999999999	0.05515415936667206
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05515415936667206
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0014770999999999999	0.05515415936667206
HODGKIN LYMPHOMA	0.0014770999999999999	0.05515415936667206
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0014770999999999999	0.05515415936667206
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05515415936667206
HEREDITARY SPHEROCYTOSIS	0.0014770999999999999	0.05515415936667206
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0014770999999999999	0.05515415936667206
STIMMLER SYNDROME	0.0014770999999999999	0.05515415936667206
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05515415936667206
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020216308855286864
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020216308855286864
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.020216308855286864
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.000541419	0.020216308855286864
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000541419	0.020216308855286864
PRADER-WILLI-LIKE SYNDROME	0.000541419	0.020216308855286864
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020216308855286864
GLYCEROL KINASE DEFICIENCY; GKD	0.000541419	0.020216308855286864
MENKES DISEASE	0.000541419	0.020216308855286864
HHHH SYNDROME	0.000541419	0.020216308855286864
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.020216308855286864
PETTIGREW SYNDROME	0.000541419	0.020216308855286864
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.020216308855286864
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020216308855286864
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020216308855286864
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020216308855286864
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020216308855286864
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020216308855286864
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020216308855286864
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020216308855286864
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020216308855286864
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020216308855286864
INFANTILE SIALIC ACID STORAGE DISEASE	0.000541419	0.020216308855286864
STT3A-CDG	0.000541419	0.020216308855286864
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020216308855286864
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.020216308855286864
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.020216308855286864
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020216308855286864
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.020216308855286864
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020216308855286864
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020216308855286864
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020216308855286864
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020216308855286864
STT3B-CDG	0.000541419	0.020216308855286864
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020216308855286864
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020216308855286864
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.020216308855286864
RAMON SYNDROME	0.000541419	0.020216308855286864
CLASSIC HOMOCYSTINURIA	0.000541419	0.020216308855286864
SSR4-CDG	0.000541419	0.020216308855286864
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020216308855286864
MONOSOMY 22Q13.3	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.020216308855286864
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000541419	0.020216308855286864
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020216308855286864
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020216308855286864
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020216308855286864
HYPOPHOSPHATASIA	0.000541419	0.020216308855286864
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020216308855286864
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020216308855286864
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020216308855286864
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020216308855286864
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.020216308855286864
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000541419	0.020216308855286864
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000541419	0.020216308855286864
ADRENOLEUKODYSTROPHY	0.000541419	0.020216308855286864
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020216308855286864
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020216308855286864
XYLOSIDASE DEFICIENCY	0.000541419	0.020216308855286864
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020216308855286864
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020216308855286864
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000541419	0.020216308855286864
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020216308855286864
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020216308855286864
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.020216308855286864
ATKIN-FLAITZ SYNDROME	0.000541419	0.020216308855286864
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.020216308855286864
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020216308855286864
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.000541419	0.020216308855286864
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.020216308855286864
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020216308855286864
CLARK-BARAITSER SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020216308855286864
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020216308855286864
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020216308855286864
PHACE SYNDROME	0.000541419	0.020216308855286864
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.020216308855286864
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020216308855286864
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020216308855286864
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000541419	0.020216308855286864
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020216308855286864
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000541419	0.020216308855286864
THREONINEMIA	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020216308855286864
TAY-SACHS DISEASE; TSD	0.000541419	0.020216308855286864
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020216308855286864
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000541419	0.020216308855286864
XQ25 DUPLICATION SYNDROME	0.000541419	0.020216308855286864
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000541419	0.020216308855286864
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000541419	0.020216308855286864
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020216308855286864
FILIPPI SYNDROME; FLPIS	0.000541419	0.020216308855286864
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020216308855286864
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.020216308855286864
MEND SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020216308855286864
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020216308855286864
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000541419	0.020216308855286864
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020216308855286864
MALAN OVERGROWTH SYNDROME	0.000541419	0.020216308855286864
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020216308855286864
HYPERPROLINEMIA TYPE 1	0.000541419	0.020216308855286864
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020216308855286864
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000541419	0.020216308855286864
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020216308855286864
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020216308855286864
MEND SYNDROME; MEND	0.000541419	0.020216308855286864
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.020216308855286864
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.020216308855286864
IMMUNODEFICIENCY 47	0.000541419	0.020216308855286864
9Q33.3Q34.11 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020216308855286864
PHENYLKETONURIA	0.000541419	0.020216308855286864
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020216308855286864
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000541419	0.020216308855286864
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020216308855286864
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020216308855286864
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020216308855286864
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020216308855286864
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020216308855286864
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020216308855286864
DIGEORGE SYNDROME; DGS	0.000541419	0.020216308855286864
STURGE-WEBER SYNDROME	0.000541419	0.020216308855286864
DPAGT1-CDG	0.000541419	0.020216308855286864
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020216308855286864
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.020216308855286864
PRADER-WILLI SYNDROME; PWS	0.000541419	0.020216308855286864
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020216308855286864
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020216308855286864
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020216308855286864
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020216308855286864
WALKER-WARBURG SYNDROME	0.000541419	0.020216308855286864
PARIETAL FORAMINA	0.000541419	0.020216308855286864
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020216308855286864
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020216308855286864
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.020216308855286864
SYSTEMIC SCLEROSIS	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020216308855286864
FETAL GAUCHER DISEASE	0.000541419	0.020216308855286864
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020216308855286864
MOGS-CDG	0.000541419	0.020216308855286864
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020216308855286864
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020216308855286864
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020216308855286864
PORPHYRIA VARIEGATA	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020216308855286864
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020216308855286864
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020216308855286864
C SYNDROME	0.000541419	0.020216308855286864
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020216308855286864
47,XYY SYNDROME	0.000541419	0.020216308855286864
SCLERODERMA	0.000541419	0.020216308855286864
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020216308855286864
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020216308855286864
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000541419	0.020216308855286864
KEUTEL SYNDROME	0.000541419	0.020216308855286864
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000541419	0.020216308855286864
SMITH-LEMLI-OPITZ SYNDROME	0.000541419	0.020216308855286864
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020216308855286864
ISOLATED SPINA BIFIDA	0.000541419	0.020216308855286864
SCRUB TYPHUS	0.000541419	0.020216308855286864
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020216308855286864
ENCEPHALITIS LETHARGICA	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020216308855286864
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000541419	0.020216308855286864
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.020216308855286864
ADDISON DISEASE	0.000541419	0.020216308855286864
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020216308855286864
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020216308855286864
GENITOPATELLAR SYNDROME	0.000541419	0.020216308855286864
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.020216308855286864
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020216308855286864
DPM1-CDG	0.000541419	0.020216308855286864
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020216308855286864
CROUZON SYNDROME	0.000541419	0.020216308855286864
ADRENOMYODYSTROPHY	0.000541419	0.020216308855286864
DARIER-WHITE DISEASE; DAR	0.000541419	0.020216308855286864
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020216308855286864
BOHRING-OPITZ SYNDROME	0.000541419	0.020216308855286864
INSULINOMA	0.000541419	0.020216308855286864
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020216308855286864
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020216308855286864
49,XXXXY SYNDROME	0.000541419	0.020216308855286864
48,XXXY SYNDROME	0.000541419	0.020216308855286864
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020216308855286864
COFFIN-SIRIS SYNDROME 1; CSS1	0.000541419	0.020216308855286864
EMANUEL SYNDROME	0.000541419	0.020216308855286864
RECOMBINANT 8 SYNDROME	0.000541419	0.020216308855286864
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020216308855286864
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020216308855286864
PAPILLORENAL SYNDROME	0.000541419	0.020216308855286864
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020216308855286864
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000541419	0.020216308855286864
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020216308855286864
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020216308855286864
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020216308855286864
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.020216308855286864
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
2Q33.1 DELETION SYNDROME	0.000541419	0.020216308855286864
HADDAD SYNDROME	0.000541419	0.020216308855286864
LASSA FEVER	0.000541419	0.020216308855286864
XQ28 (MECP2) DUPLICATION	0.000541419	0.020216308855286864
SECONDARY SYRINGOMYELIA	0.000541419	0.020216308855286864
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020216308855286864
1P36 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
NON-DISTAL MONOSOMY 20Q	0.000541419	0.020216308855286864
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020216308855286864
DISTAL MONOSOMY 19P13.3	0.000541419	0.020216308855286864
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020216308855286864
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020216308855286864
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020216308855286864
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020216308855286864
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020216308855286864
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020216308855286864
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020216308855286864
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020216308855286864
HOLOPROSENCEPHALY 2; HPE2	0.000541419	0.020216308855286864
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020216308855286864
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020216308855286864
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.020216308855286864
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020216308855286864
FG SYNDROME TYPE 1	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020216308855286864
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020216308855286864
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020216308855286864
15Q24 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020216308855286864
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020216308855286864
KBG SYNDROME	0.000541419	0.020216308855286864
KABUKI SYNDROME 1	0.000541419	0.020216308855286864
PALLISTER-HALL SYNDROME	0.000541419	0.020216308855286864
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020216308855286864
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020216308855286864
HUNTINGTON DISEASE; HD	0.000541419	0.020216308855286864
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020216308855286864
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020216308855286864
PITUITARY STALK INTERRUPTION SYNDROME	0.000541419	0.020216308855286864
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020216308855286864
ALG1-CDG	0.000541419	0.020216308855286864
ALG3-CDG	0.000541419	0.020216308855286864
PETERS-PLUS SYNDROME; PTRPLS	0.000541419	0.020216308855286864
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020216308855286864
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000541419	0.020216308855286864
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020216308855286864
KAPUR-TORIELLO SYNDROME	0.000541419	0.020216308855286864
KETOADIPICACIDURIA	0.000541419	0.020216308855286864
KEUTEL SYNDROME; KTLS	0.000541419	0.020216308855286864
KIFAFA SEIZURE DISORDER	0.000541419	0.020216308855286864
22Q11.2 DELETION SYNDROME	0.000541419	0.020216308855286864
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020216308855286864
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020216308855286864
MACDERMOT-WINTER SYNDROME	0.000541419	0.020216308855286864
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000541419	0.020216308855286864
CRANIOPHARYNGIOMA	0.000541419	0.020216308855286864
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020216308855286864
MARDEN-WALKER SYNDROME	0.000541419	0.020216308855286864
VICI SYNDROME; VICIS	0.000541419	0.020216308855286864
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020216308855286864
CENTRONUCLEAR MYOPATHY	0.000541419	0.020216308855286864
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020216308855286864
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020216308855286864
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000541419	0.020216308855286864
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020216308855286864
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020216308855286864
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020216308855286864
NETHERTON SYNDROME	0.000541419	0.020216308855286864
ALSTRÖM SYNDROME	0.000541419	0.020216308855286864
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020216308855286864
NARP SYNDROME	0.000541419	0.020216308855286864
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020216308855286864
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020216308855286864
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020216308855286864
HYPERPROLINEMIA, TYPE II	0.000541419	0.020216308855286864
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
LIPOID PROTEINOSIS	0.000541419	0.020216308855286864
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020216308855286864
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020216308855286864
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020216308855286864
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020216308855286864
16P13.2 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020216308855286864
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020216308855286864
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.000541419	0.020216308855286864
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020216308855286864
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020216308855286864
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020216308855286864
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020216308855286864
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020216308855286864
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020216308855286864
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020216308855286864
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020216308855286864
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020216308855286864
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.020216308855286864
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020216308855286864
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000541419	0.020216308855286864
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000541419	0.020216308855286864
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000541419	0.020216308855286864
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020216308855286864
OHDO SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020216308855286864
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020216308855286864
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020216308855286864
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020216308855286864
LEBER CONGENITAL AMAUROSIS	0.000541419	0.020216308855286864
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020216308855286864
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020216308855286864
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020216308855286864
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020216308855286864
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.020216308855286864
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020216308855286864
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020216308855286864
RUBINSTEIN-TAYBI SYNDROME	0.000541419	0.020216308855286864
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020216308855286864
CROME SYNDROME	0.000541419	0.020216308855286864
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020216308855286864
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020216308855286864
MONOSOMY 9Q22.3	0.000541419	0.020216308855286864
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.020216308855286864
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020216308855286864
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020216308855286864
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020216308855286864
COHEN SYNDROME	0.000541419	0.020216308855286864
DEND SYNDROME	0.000541419	0.020216308855286864
EPISODIC ATAXIA TYPE 3	0.000541419	0.020216308855286864
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020216308855286864
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020216308855286864
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020216308855286864
CLASSIC PHENYLKETONURIA	0.000541419	0.020216308855286864
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020216308855286864
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.020216308855286864
HEREDITARY COPROPORPHYRIA	0.000541419	0.020216308855286864
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020216308855286864
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020216308855286864
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020216308855286864
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.020216308855286864
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020216308855286864
RABIES	0.000541419	0.020216308855286864
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020216308855286864
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020216308855286864
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.020216308855286864
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020216308855286864
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020216308855286864
HYPER-BETA-ALANINEMIA	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000541419	0.020216308855286864
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.020216308855286864
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.020216308855286864
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000541419	0.020216308855286864
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000541419	0.020216308855286864
HOLOPROSENCEPHALY 1; HPE1	0.000541419	0.020216308855286864
MOWAT-WILSON SYNDROME; MOWS	0.000541419	0.020216308855286864
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020216308855286864
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020216308855286864
HARTNUP DISORDER	0.000541419	0.020216308855286864
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.020216308855286864
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020216308855286864
6Q TERMINAL DELETION SYNDROME	0.000541419	0.020216308855286864
BERNARD-SOULIER SYNDROME	0.000541419	0.020216308855286864
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020216308855286864
GAUCHER DISEASE, TYPE II	0.000541419	0.020216308855286864
FRYNS SYNDROME; FRNS	0.000541419	0.020216308855286864
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020216308855286864
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020216308855286864
FOUNTAIN SYNDROME	0.000541419	0.020216308855286864
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020216308855286864
EPILEPSY-TELANGIECTASIA	0.000541419	0.020216308855286864
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000541419	0.020216308855286864
PORPHYRIA	0.000541419	0.020216308855286864
PRADER-WILLI SYNDROME	0.000541419	0.020216308855286864
PROTEUS SYNDROME	0.000541419	0.020216308855286864
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020216308855286864
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020216308855286864
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020216308855286864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000541419	0.020216308855286864
FRONTAL ENCEPHALOCELE	0.000541419	0.020216308855286864
TENORIO SYNDROME; TNORS	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000541419	0.020216308855286864
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020216308855286864
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000541419	0.020216308855286864
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020216308855286864
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000541419	0.020216308855286864
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.020216308855286864
ACROMELIC FRONTONASAL DYSPLASIA	0.000541419	0.020216308855286864
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020216308855286864
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.020216308855286864
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.020216308855286864
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.020216308855286864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020216308855286864
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020216308855286864
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020216308855286864
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.020216308855286864
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020216308855286864
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020216308855286864
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020216308855286864
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020216308855286864
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020216308855286864
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020216308855286864
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000541419	0.020216308855286864
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.020216308855286864
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.020216308855286864
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020216308855286864
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.020216308855286864
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020216308855286864
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020216308855286864
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.020216308855286864
WOLCOTT-RALLISON SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020216308855286864
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020216308855286864
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.020216308855286864
COFFIN-SIRIS SYNDROME 5	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020216308855286864
2P21 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
DISTAL MONOSOMY 7Q36	0.000541419	0.020216308855286864
2Q24 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.000541419	0.020216308855286864
MONOSOMY 18Q	0.000541419	0.020216308855286864
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020216308855286864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000541419	0.020216308855286864
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.020216308855286864
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020216308855286864
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.020216308855286864
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020216308855286864
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020216308855286864
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020216308855286864
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020216308855286864
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020216308855286864
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020216308855286864
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020216308855286864
DESANTO-SHINAWI SYNDROME	0.000541419	0.020216308855286864
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.020216308855286864
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020216308855286864
DISTAL TRISOMY 15Q	0.000541419	0.020216308855286864
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.020216308855286864
MOSAIC TRISOMY 14	0.000541419	0.020216308855286864
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.020216308855286864
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020216308855286864
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.020216308855286864
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020216308855286864
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020216308855286864
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020216308855286864
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020216308855286864
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020216308855286864
INFANTILE LIVER FAILURE SYNDROME 1	0.000541419	0.020216308855286864
NEPHROGENIC DIABETES INSIPIDUS	0.000541419	0.020216308855286864
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020216308855286864
MATERNAL PHENYLKETONURIA	0.000541419	0.020216308855286864
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020216308855286864
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020216308855286864
SCHAAF-YANG SYNDROME; SHFYNG	0.000541419	0.020216308855286864
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020216308855286864
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020216308855286864
COWDEN SYNDROME 5; CWS5	0.000541419	0.020216308855286864
DUANE RETRACTION SYNDROME	0.000541419	0.020216308855286864
COWDEN SYNDROME 6; CWS6	0.000541419	0.020216308855286864
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020216308855286864
SANJAD-SAKATI SYNDROME	0.000541419	0.020216308855286864
LISSENCEPHALY 5; LIS5	0.000541419	0.020216308855286864
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020216308855286864
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020216308855286864
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.020216308855286864
JACOBSEN SYNDROME	0.000541419	0.020216308855286864
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020216308855286864
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020216308855286864
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020216308855286864
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
CONGENITAL HYDROCEPHALUS	0.000541419	0.020216308855286864
HYDRANENCEPHALY	0.000541419	0.020216308855286864
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020216308855286864
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020216308855286864
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.020216308855286864
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020216308855286864
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020216308855286864
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020216308855286864
WEBB-DATTANI SYNDROME; WEDAS	0.000541419	0.020216308855286864
FRYNS SYNDROME	0.000541419	0.020216308855286864
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020216308855286864
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020216308855286864
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020216308855286864
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020216308855286864
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020216308855286864
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020216308855286864
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.020216308855286864
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.020216308855286864
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020216308855286864
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020216308855286864
MOWAT-WILSON SYNDROME	0.000541419	0.020216308855286864
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020216308855286864
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020216308855286864
DONNAI-BARROW SYNDROME	0.000541419	0.020216308855286864
HENNEKAM SYNDROME	0.000541419	0.020216308855286864
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020216308855286864
CYSTATHIONINURIA	0.000541419	0.020216308855286864
HARROD SYNDROME	0.000541419	0.020216308855286864
HALL-RIGGS SYNDROME	0.000541419	0.020216308855286864
DISTAL MONOSOMY 15Q	0.000541419	0.020216308855286864
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020216308855286864
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020216308855286864
2Q37 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020216308855286864
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020216308855286864
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020216308855286864
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020216308855286864
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000541419	0.020216308855286864
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020216308855286864
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000541419	0.020216308855286864
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020216308855286864
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.020216308855286864
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.020216308855286864
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000541419	0.020216308855286864
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020216308855286864
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020216308855286864
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.020216308855286864
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.020216308855286864
ROMANO-WARD SYNDROME	0.000541419	0.020216308855286864
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020216308855286864
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020216308855286864
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.020216308855286864
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020216308855286864
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000541419	0.020216308855286864
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.020216308855286864
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020216308855286864
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020216308855286864
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.020216308855286864
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020216308855286864
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000541419	0.020216308855286864
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000541419	0.020216308855286864
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000541419	0.020216308855286864
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000541419	0.020216308855286864
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020216308855286864
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020216308855286864
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000541419	0.020216308855286864
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.020216308855286864
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020216308855286864
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000541419	0.020216308855286864
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020216308855286864
COFFIN-SIRIS SYNDROME	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000541419	0.020216308855286864
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020216308855286864
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.020216308855286864
XQ21 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020216308855286864
SHASHI-PENA SYNDROME; SHAPNS	0.000541419	0.020216308855286864
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.020216308855286864
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.020216308855286864
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020216308855286864
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020216308855286864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000541419	0.020216308855286864
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000541419	0.020216308855286864
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.020216308855286864
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.020216308855286864
COFS SYNDROME	0.000541419	0.020216308855286864
LISSENCEPHALY 8; LIS8	0.000541419	0.020216308855286864
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020216308855286864
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020216308855286864
MIRAGE SYNDROME; MIRAGE	0.000541419	0.020216308855286864
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020216308855286864
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.020216308855286864
KNOBLOCH SYNDROME	0.000541419	0.020216308855286864
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020216308855286864
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000541419	0.020216308855286864
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020216308855286864
CRYPTOCOCCOSIS	0.000541419	0.020216308855286864
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020216308855286864
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020216308855286864
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020216308855286864
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020216308855286864
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020216308855286864
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020216308855286864
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020216308855286864
AL KAISSI SYNDROME; ALKAS	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020216308855286864
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000541419	0.020216308855286864
BOWEN-CONRADI SYNDROME	0.000541419	0.020216308855286864
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020216308855286864
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020216308855286864
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020216308855286864
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020216308855286864
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.020216308855286864
BETA-MANNOSIDOSIS	0.000541419	0.020216308855286864
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000541419	0.020216308855286864
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000541419	0.020216308855286864
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.020216308855286864
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000541419	0.020216308855286864
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020216308855286864
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.020216308855286864
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.020216308855286864
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000541419	0.020216308855286864
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020216308855286864
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020216308855286864
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020216308855286864
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.020216308855286864
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020216308855286864
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020216308855286864
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.020216308855286864
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000541419	0.020216308855286864
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020216308855286864
C SYNDROME	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000541419	0.020216308855286864
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000541419	0.020216308855286864
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020216308855286864
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020216308855286864
WIEDEMANN-STEINER SYNDROME	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.020216308855286864
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.020216308855286864
SIALURIA	0.000541419	0.020216308855286864
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000541419	0.020216308855286864
KAGAMI-OGATA SYNDROME	0.000541419	0.020216308855286864
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020216308855286864
15Q OVERGROWTH SYNDROME	0.000541419	0.020216308855286864
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.020216308855286864
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020216308855286864
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.000541419	0.020216308855286864
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000541419	0.020216308855286864
LUJO HEMORRHAGIC FEVER	0.000541419	0.020216308855286864
RIFT VALLEY FEVER	0.000541419	0.020216308855286864
NOCARDIOSIS	0.000541419	0.020216308855286864
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020216308855286864
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020216308855286864
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000541419	0.020216308855286864
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020216308855286864
RENPENNING SYNDROME	0.000541419	0.020216308855286864
PROPIONIC ACIDEMIA	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000541419	0.020216308855286864
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000541419	0.020216308855286864
PHACE ASSOCIATION	0.000541419	0.020216308855286864
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.020216308855286864
LATHOSTEROLOSIS	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020216308855286864
LISSENCEPHALY 1; LIS1	0.000541419	0.020216308855286864
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020216308855286864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020216308855286864
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.020216308855286864
RUVALCABA SYNDROME	0.000541419	0.020216308855286864
EMANUEL SYNDROME	0.000541419	0.020216308855286864
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020216308855286864
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000541419	0.020216308855286864
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020216308855286864
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000541419	0.020216308855286864
KLEEFSTRA SYNDROME	0.000541419	0.020216308855286864
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020216308855286864
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.020216308855286864
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020216308855286864
PROLACTINOMA	0.000541419	0.020216308855286864
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020216308855286864
PORENCEPHALY	0.000541419	0.020216308855286864
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.020216308855286864
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020216308855286864
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000541419	0.020216308855286864
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020216308855286864
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.020216308855286864
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020216308855286864
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020216308855286864
RAMON SYNDROME	0.000541419	0.020216308855286864
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020216308855286864
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020216308855286864
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020216308855286864
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020216308855286864
CHROMOSOME 10Q26 DELETION SYNDROME	0.000541419	0.020216308855286864
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.020216308855286864
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020216308855286864
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.020216308855286864
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000541419	0.020216308855286864
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.020216308855286864
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020216308855286864
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020216308855286864
ISOLATED BILIARY ATRESIA	0.000541419	0.020216308855286864
BOHRING-OPITZ SYNDROME	0.000541419	0.020216308855286864
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020216308855286864
CRONKHITE-CANADA SYNDROME	0.000541419	0.020216308855286864
19P13.13 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020216308855286864
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.020216308855286864
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020216308855286864
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000541419	0.020216308855286864
TIMOTHY SYNDROME; TS	0.000541419	0.020216308855286864
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.020216308855286864
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000541419	0.020216308855286864
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.000541419	0.020216308855286864
GURRIERI SYNDROME	0.000541419	0.020216308855286864
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020216308855286864
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020216308855286864
GALACTOSIALIDOSIS	0.000541419	0.020216308855286864
FUCOSIDOSIS	0.000541419	0.020216308855286864
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020216308855286864
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020216308855286864
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020216308855286864
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020216308855286864
CODAS SYNDROME	0.000541419	0.020216308855286864
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000541419	0.020216308855286864
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020216308855286864
WIEACKER-WOLFF SYNDROME	0.000541419	0.020216308855286864
DISTAL MONOSOMY 1Q	0.000541419	0.020216308855286864
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020216308855286864
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020216308855286864
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.000541419	0.020216308855286864
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.020216308855286864
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.020216308855286864
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020216308855286864
GLIOBLASTOMA	0.000541419	0.020216308855286864
BAND HETEROTOPIA; BH	0.000541419	0.020216308855286864
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020216308855286864
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000541419	0.020216308855286864
CHIME SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020216308855286864
CRANIOSYNOSTOSIS 2	0.000541419	0.020216308855286864
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020216308855286864
TETRASOMY 9P	0.000541419	0.020216308855286864
TETRASOMY 5P	0.000541419	0.020216308855286864
TETRASOMY 18P	0.000541419	0.020216308855286864
DUPLICATION/INVERSION 15Q11	0.000541419	0.020216308855286864
MERCURY POISONING	0.000541419	0.020216308855286864
ISOVALERIC ACIDEMIA	0.000541419	0.020216308855286864
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020216308855286864
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.020216308855286864
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.020216308855286864
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020216308855286864
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020216308855286864
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020216308855286864
FILIPPI SYNDROME	0.000541419	0.020216308855286864
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020216308855286864
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020216308855286864
MUENKE SYNDROME	0.000541419	0.020216308855286864
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020216308855286864
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.020216308855286864
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020216308855286864
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020216308855286864
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020216308855286864
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000541419	0.020216308855286864
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020216308855286864
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020216308855286864
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.020216308855286864
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020216308855286864
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020216308855286864
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020216308855286864
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020216308855286864
DISTAL TRISOMY 17Q	0.000541419	0.020216308855286864
PIERPONT SYNDROME	0.000541419	0.020216308855286864
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020216308855286864
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020216308855286864
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020216308855286864
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020216308855286864
DUBOWITZ SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.020216308855286864
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020216308855286864
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020216308855286864
KAGAMI-OGATA SYNDROME	0.000541419	0.020216308855286864
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
19P13.12 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020216308855286864
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.020216308855286864
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020216308855286864
PINEOBLASTOMA	0.000541419	0.020216308855286864
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.020216308855286864
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020216308855286864
SUBEPENDYMOMA	0.000541419	0.020216308855286864
EPENDYMOMA	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000541419	0.020216308855286864
MICROSPORIDIOSIS	0.000541419	0.020216308855286864
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020216308855286864
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020216308855286864
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.020216308855286864
15Q14 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.020216308855286864
MONOSOMY 9P	0.000541419	0.020216308855286864
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020216308855286864
PERRAULT SYNDROME 3	0.000541419	0.020216308855286864
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000541419	0.020216308855286864
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020216308855286864
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020216308855286864
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020216308855286864
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020216308855286864
MOYNAHAN SYNDROME	0.000541419	0.020216308855286864
MOYAMOYA DISEASE	0.000541419	0.020216308855286864
MOMO SYNDROME	0.000541419	0.020216308855286864
CK SYNDROME	0.000541419	0.020216308855286864
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.020216308855286864
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.020216308855286864
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020216308855286864
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020216308855286864
LOWRY-MACLEAN SYNDROME	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020216308855286864
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020216308855286864
4Q21 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000541419	0.020216308855286864
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020216308855286864
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020216308855286864
CITRULLINEMIA TYPE II	0.000541419	0.020216308855286864
8P11.2 DELETION SYNDROME	0.000541419	0.020216308855286864
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020216308855286864
6Q25 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
2Q31.1 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
COFFIN-SIRIS SYNDROME 3; CSS3	0.000541419	0.020216308855286864
COFFIN-SIRIS SYNDROME 4; CSS4	0.000541419	0.020216308855286864
MICRO SYNDROME	0.000541419	0.020216308855286864
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
AICA-RIBOSIDURIA	0.000541419	0.020216308855286864
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020216308855286864
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000541419	0.020216308855286864
PONTINE TEGMENTAL CAP DYSPLASIA	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.020216308855286864
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.020216308855286864
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
HOLOPROSENCEPHALY 7	0.000541419	0.020216308855286864
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.020216308855286864
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000541419	0.020216308855286864
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.000541419	0.020216308855286864
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020216308855286864
GLASS SYNDROME	0.000541419	0.020216308855286864
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020216308855286864
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020216308855286864
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.020216308855286864
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020216308855286864
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020216308855286864
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020216308855286864
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020216308855286864
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020216308855286864
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000541419	0.020216308855286864
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020216308855286864
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000541419	0.020216308855286864
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000541419	0.020216308855286864
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
PITT-HOPKINS SYNDROME	0.000541419	0.020216308855286864
PITT-HOPKINS SYNDROME	0.000541419	0.020216308855286864
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.020216308855286864
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000541419	0.020216308855286864
TARP SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020216308855286864
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020216308855286864
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.020216308855286864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020216308855286864
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020216308855286864
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020216308855286864
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.020216308855286864
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020216308855286864
611961 STEVENSON-CAREY SYNDROME	0.000541419	0.020216308855286864
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000541419	0.020216308855286864
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.020216308855286864
COG5-CDG	0.000541419	0.020216308855286864
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020216308855286864
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020216308855286864
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000541419	0.020216308855286864
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.020216308855286864
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.020216308855286864
XP21 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020216308855286864
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
LISSENCEPHALY 4	0.000541419	0.020216308855286864
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.020216308855286864
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020216308855286864
17Q12 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.020216308855286864
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.020216308855286864
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020216308855286864
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000541419	0.020216308855286864
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.020216308855286864
L1 SYNDROME	0.000541419	0.020216308855286864
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020216308855286864
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020216308855286864
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020216308855286864
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.020216308855286864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020216308855286864
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020216308855286864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020216308855286864
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000541419	0.020216308855286864
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020216308855286864
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.020216308855286864
THANATOPHORIC DYSPLASIA	0.000541419	0.020216308855286864
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.020216308855286864
TRISOMY 8P	0.000541419	0.020216308855286864
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020216308855286864
